var title_f40_53_41808="Stool sample 2";
var content_f40_53_41808=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F65371&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F65371&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Stool sample 2",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 359px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_53_41808=[""].join("\n");
var outline_f40_53_41808=null;
var title_f40_53_41809="Gram stain urine 3";
var content_f40_53_41809=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F50082&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F50082&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gram stain urine 3",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 260px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_53_41809=[""].join("\n");
var outline_f40_53_41809=null;
var title_f40_53_41810="Patient information: Rib fractures in adults (The Basics)";
var content_f40_53_41810=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/82821\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?7/58/8096\">",
"         Rib bones",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?18/13/18647\">",
"          Foods and drinks with calcium and vitamin D",
"         </a>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?35/12/36034\">",
"         Patient information: Calcium and vitamin D for bone health (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?29/34/30243\">",
"         Patient information: Fractures (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?39/15/40178\">",
"         Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?35/18/36130\">",
"         Patient information: Pneumonia in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?17/46/18146\">",
"         Patient information: Quitting smoking (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?22/60/23491\">",
"         Patient information: Calcium and vitamin D for bone health (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?2/13/2262\">",
"         Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?29/38/30308\">",
"         Patient information: Pneumonia in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?19/13/19670\">",
"         Patient information: Quitting smoking (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Rib fractures in adults (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/rib-fractures-in-adults-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H20931513\">",
"      <span class=\"h1\">",
"       What is a rib fracture?",
"      </span>",
"      &nbsp;&mdash;&nbsp;A &ldquo;fracture&rdquo; is another word for a broken bone. A rib fracture is when a person breaks a rib bone (",
"      <a class=\"graphic graphic_figure graphicRef82794 \" href=\"mobipreview.htm?7/58/8096\">",
"       figure 1",
"      </a>",
"      ).",
"     </p>",
"     <p>",
"      Most rib fractures happen after an injury to the chest. If this injury is severe, it can also damage organs in the chest or belly.",
"     </p>",
"     <p>",
"      Some rib fractures, called &ldquo;stress fractures,&rdquo; do not happen after an injury. Instead, they are caused by a severe cough or a motion people do over and over, like swinging a golf club.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H20931545\">",
"      <span class=\"h1\">",
"       What are the symptoms of a rib fracture?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The most common symptom of a rib fracture is pain. The pain is usually worse when you press on the injured area or take a deep breath. Some people also have bruising over the injured area.",
"     </p>",
"     <p>",
"      A stress fracture also causes pain, but the pain usually starts slowly and gets worse over time.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H20931560\">",
"      <span class=\"h1\">",
"       Is there a test for a rib fracture?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Your doctor or nurse will ask about your symptoms and do an exam. He or she might order a chest X-ray.",
"     </p>",
"     <p>",
"      Some people need other imaging tests, such as a CT scan, bone scan, or ultrasound. Imaging tests create pictures of the inside of the body.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H20931575\">",
"      <span class=\"h1\">",
"       How are rib fractures treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatment depends on how many ribs you broke and your other injuries.",
"     </p>",
"     <p>",
"      People with 3 or more broken ribs or other serious injuries usually need treatment in the hospital.",
"     </p>",
"     <p>",
"      People who do not need treatment in the hospital are treated with pain-relieving medicines. Treating the pain is important, because when people have rib pain, they try to keep their ribs from moving too much. Then they don&rsquo;t breathe in and out as deeply as they should. When people don&rsquo;t breathe in and out as deeply as they should, some of the small airways in the lungs can close off. This raises the chances of getting a lung infection, called &ldquo;pneumonia.&rdquo;",
"     </p>",
"     <p>",
"      To treat your pain, your doctor can use:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Strong pain medicines",
"       </li>",
"       <li>",
"        Nonsteroidal anti-inflammatory drugs, also called &ldquo;NSAIDs&rdquo; &ndash; NSAIDS are a large group of medicines that includes",
"        <a class=\"drug drug_patient\" href=\"mobipreview.htm?14/17/14614?source=see_link\">",
"         ibuprofen",
"        </a>",
"        (sample brand names: Advil&reg;, Motrin&reg;) and",
"        <a class=\"drug drug_patient\" href=\"mobipreview.htm?43/35/44597?source=see_link\">",
"         naproxen",
"        </a>",
"        (sample brand names: Aleve&reg;, Naprosyn&reg;).",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Your doctor will probably also recommend a treatment to help prevent your small airways from closing off. This treatment, called &ldquo;incentive spirometry,&rdquo; involves breathing deeply into a hand-held device a number of times each day.",
"     </p>",
"     <p>",
"      Treatment for a stress fracture involves avoiding the activity that caused your stress fracture for 4 to 6 weeks. Then you can slowly restart that activity.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H20931590\">",
"      <span class=\"h1\">",
"       How long do rib fractures take to heal?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Rib fractures can take weeks to months to heal, depending on how mild or serious the fracture is.",
"     </p>",
"     <p>",
"      Healing time also depends on the person. Healthy children usually heal very quickly. Older adults or adults with other medical problems can take much longer to heal.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H20931605\">",
"      <span class=\"h1\">",
"       Can I do anything to improve the healing process?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. It&rsquo;s important to follow all of your doctor&rsquo;s instructions while your fracture is healing. He or she will probably recommend that you eat a healthy diet that includes getting enough calcium, vitamin D, and protein (",
"      <a class=\"graphic graphic_figure graphicRef79375 \" href=\"mobipreview.htm?18/13/18647\">",
"       figure 2",
"      </a>",
"      ). He or she will also probably recommend that you:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Avoid doing certain activities.",
"       </li>",
"       <li>",
"        Avoid smoking. A fracture can take longer to heal if you smoke.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H20931637\">",
"      <span class=\"h1\">",
"       When should I call my doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;After treatment, your doctor or nurse will tell you when to call him or her. In general, you should call him or her if:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        You get a fever.",
"       </li>",
"       <li>",
"        You have trouble breathing.",
"       </li>",
"       <li>",
"        You have a cough that is getting worse.",
"       </li>",
"       <li>",
"        You have severe pain or are very weak.",
"       </li>",
"       <li>",
"        Your skin looks more pale than usual.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H20931652\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?29/34/30243?source=see_link\">",
"       Patient information: Fractures (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?35/18/36130?source=see_link\">",
"       Patient information: Pneumonia in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?39/15/40178?source=see_link\">",
"       Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?35/12/36034?source=see_link\">",
"       Patient information: Calcium and vitamin D for bone health (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?17/46/18146?source=see_link\">",
"       Patient information: Quitting smoking (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?29/38/30308?source=see_link\">",
"       Patient information: Pneumonia in adults (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?2/13/2262?source=see_link\">",
"       Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?19/13/19670?source=see_link\">",
"       Patient information: Quitting smoking (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?22/60/23491?source=see_link\">",
"       Patient information: Calcium and vitamin D for bone health (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?40/53/41810?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 82821 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.234.146.186-4E1BBEB838-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_53_41810=[""].join("\n");
var outline_f40_53_41810=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20931513\">",
"      What is a rib fracture?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20931545\">",
"      What are the symptoms of a rib fracture?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20931560\">",
"      Is there a test for a rib fracture?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20931575\">",
"      How are rib fractures treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20931590\">",
"      How long do rib fractures take to heal?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20931605\">",
"      Can I do anything to improve the healing process?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20931637\">",
"      When should I call my doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20931652\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/82821\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?7/58/8096\">",
"      Rib bones",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?18/13/18647\">",
"       Foods and drinks with calcium and vitamin D",
"      </a>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?22/60/23491?source=related_link\">",
"      Patient information: Calcium and vitamin D for bone health (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?35/12/36034?source=related_link\">",
"      Patient information: Calcium and vitamin D for bone health (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?29/34/30243?source=related_link\">",
"      Patient information: Fractures (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?2/13/2262?source=related_link\">",
"      Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?39/15/40178?source=related_link\">",
"      Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?29/38/30308?source=related_link\">",
"      Patient information: Pneumonia in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?35/18/36130?source=related_link\">",
"      Patient information: Pneumonia in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?19/13/19670?source=related_link\">",
"      Patient information: Quitting smoking (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?17/46/18146?source=related_link\">",
"      Patient information: Quitting smoking (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_53_41811="Ganciclovir (ophthalmic): Patient drug information";
var content_f40_53_41811=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Ganciclovir (ophthalmic): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?6/5/6228?source=see_link\">",
"     see \"Ganciclovir (ophthalmic): Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?5/58/6052?source=see_link\">",
"     see \"Ganciclovir (ophthalmic): Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F8106936\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Vitrasert&reg;;",
"     </li>",
"     <li>",
"      Zirgan&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10276990\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691682",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat a viral infection of the eyes.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10276989\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702188",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to ganciclovir or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10276994\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10276995\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698045",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Eye irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697908",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Blurred eyesight.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10276997\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad eye irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10276992\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694913",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For the eye only.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694806",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not wear contact lenses while using this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694779",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not touch the container tip to the eye, lid, or other skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696124",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tilt your head back and drop drug into the eye.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10276993\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696583",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use 2 doses or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10276998\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature. Do not freeze.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10276999\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15554 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.247-05EE575892-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_53_41811=[""].join("\n");
var outline_f40_53_41811=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8106936\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10276990\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10276989\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10276994\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10276995\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10276997\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10276992\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10276993\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10276998\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10276999\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?6/5/6228?source=related_link\">",
"      Ganciclovir (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?5/58/6052?source=related_link\">",
"      Ganciclovir (ophthalmic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?24/3/24630?source=related_link\">",
"      Ganciclovir (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?30/18/31012?source=related_link\">",
"      Ganciclovir (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?13/42/13990?source=related_link\">",
"      Ganciclovir (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_53_41812="Lanthanum carbonate: Patient drug information";
var content_f40_53_41812=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Lanthanum carbonate: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/37/28244?source=see_link\">",
"     see \"Lanthanum carbonate: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F186951\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Fosrenol&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F5594603\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Fosrenol&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F13253862\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10014139\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691408",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to lower high phosphate levels.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10014138\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702360",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to lanthanum or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3478062",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Bowel block, low phosphate levels, slow-moving bowel tract, or enlarged colon.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10014143\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696896",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take other drugs within 2 hours of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697645",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor that you use this drug if you are getting x-rays near the belly.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10014144\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10014146\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699014",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very hard stools (constipation).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10014141\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695907",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug with food.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694604",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chewable tablet: Chew or crush well. Mix crushed tablet with food. Do not swallow it whole.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10014142\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10014147\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10014148\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11776 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-58.240.98.179-AEB5EC0217-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_53_41812=[""].join("\n");
var outline_f40_53_41812=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F186951\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5594603\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13253862\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014139\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014138\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014143\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014144\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014146\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014141\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014142\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014147\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014148\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?27/37/28244?source=related_link\">",
"      Lanthanum carbonate: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_53_41813="ICD lead systems Chest film";
var content_f40_53_41813=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F56923&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F56923&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 573px\">",
"   <div class=\"ttl\">",
"    Different ICD lead systems",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 553px; height: 314px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest radiographs of two different implantable cardioverter-defibrillator (ICD) systems. Left panel shows an ICD epicardial lead system. Epicardial sensing electrodes are located on the left ventricle (arrow) and the three epicardial patch electrodes are located on the right atrium, and the inferior and lateral walls of the left ventricle. Right panel shows a transvenous ICD lead system with a pulse generator in the pectoral region.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Douglas Kopp, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_53_41813=[""].join("\n");
var outline_f40_53_41813=null;
var title_f40_53_41814="Nervus intermedius";
var content_f40_53_41814=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F68923&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F68923&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 564px\">",
"   <div class=\"ttl\">",
"    Anatomy of nervus intermedius",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 544px; height: 528px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_53_41814=[""].join("\n");
var outline_f40_53_41814=null;
var title_f40_53_41815="Medial approach to open repair of popliteal aneurysm";
var content_f40_53_41815=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F76224&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F76224&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 527px\">",
"   <div class=\"ttl\">",
"    Medial approach to open repair of popliteal aneurysm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 507px; height: 692px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Right lower extremity popliteal artery&nbsp;aneurysm repair: With the medial approach, the popliteal artery aneurysm is left in-situ and bypassed using a segment of saphenous vein. The incision (dotted black line) is made along the medial leg (A). The popliteal artery aneurysm&nbsp;is ligated proximal and distal to the aneurysm to exclude it from the circulation (B).&nbsp;The vein graft can be tunnelled subcutaneously along the medial aspect of the knee or positioned adjacent the popliteal artery (inset) depending upon the extent of the bypass, patient anatomy, and operator preference (C).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_53_41815=[""].join("\n");
var outline_f40_53_41815=null;
var title_f40_53_41816="Buprenorphine: Drug information";
var content_f40_53_41816=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Buprenorphine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?42/30/43494?source=see_link\">",
"    see \"Buprenorphine: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?25/29/26071?source=see_link\">",
"    see \"Buprenorphine: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F11370705\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F143056\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Buprenex&reg;;",
"     </li>",
"     <li>",
"      Butrans&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F143057\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Butrans&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F143100\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Analgesic, Opioid;",
"     </li>",
"     <li>",
"      Analgesic, Opioid Partial Agonist",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F143061\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Acute pain (moderate-to-severe): Note: Long-term use is not recommended.",
"     </b>",
"     The following recommendations are guidelines and do not represent the maximum doses that may be required in all patients. Doses should be titrated to pain relief/prevention. In high-risk patients (eg, elderly, debilitated, presence of respiratory disease) and/or concurrent CNS depressant use, reduce dose by one-half. Buprenorphine has an analgesic ceiling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      I.M.:",
"     </i>",
"     Initial: Opiate-naive: 0.3 mg every 6-8 hours as needed; initial dose (up to 0.3 mg) may be repeated once in 30-60 minutes after the initial dose if needed; usual dosage range: 0.15-0.6 mg every 4-8 hours as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Slow I.V.:",
"     </i>",
"     Initial: Opiate-naive: 0.3 mg every 6-8 hours as needed; initial dose (up to 0.3 mg) may be repeated once in 30-60 minutes after the initial dose if needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Chronic pain (moderate-to-severe):",
"     </b>",
"     Transdermal patch:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Opioid-naive patients: Initial: 5",
"     <b>",
"      mcg",
"     </b>",
"     /hour applied once every 7 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Opioid-experienced patients (conversion from other opioids to buprenorphine): Taper the current around-the-clock opioid for up to 7 days to &le;30 mg/day of oral morphine or equivalent before initiating therapy. Short-acting analgesics as needed may be continued until analgesia with transdermal buprenorphine is attained. There is a potential for buprenorphine to precipitate withdrawal in patients already receiving opioids.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Patients who were receiving daily dose of &lt;30 mg of oral morphine equivalents: Initial: 5",
"     <b>",
"      mcg",
"     </b>",
"     /hour applied once every 7 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Patients who were receiving daily dose of 30-80 mg of oral morphine equivalents: Initial: 10",
"     <b>",
"      mcg",
"     </b>",
"     /hour applied once every 7 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Patient who were receiving daily dose of &gt;80 mg of oral morphine equivalents: Buprenorphine transdermal patch, even at the maximum dose of 20",
"     <b>",
"      mcg",
"     </b>",
"     /hour applied once every 7 days, may not provide adequate analgesia;",
"     <b>",
"      consider the use of an alternate analgesic.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dose titration (opioid-naive or opioid-experienced patients): May increase dose, based on patient&rsquo;s supplemental short-acting analgesic requirements, with a minimum titration interval of 72 hours (maximum dose: 20",
"     <b>",
"      mcg",
"     </b>",
"     /hour applied once every 7 days; risk for QT",
"     <sub>",
"      c",
"     </sub>",
"     prolongation increases with doses &ge;20",
"     <b>",
"      mcg",
"     </b>",
"     /hour patch).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Discontinuation of therapy: Taper dose gradually every 7 days to prevent withdrawal in the physically dependent patient; consider initiating immediate-release opioids, if needed.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Opiate withdrawal in heroin-dependent hospitalized patients (unlabeled use):",
"     </b>",
"     I.V. infusion: 0.3-0.9 mg (diluted in 50-100 mL of NS) over 20-30 minutes every 6-12 hours (Welsh, 2002)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Opioid dependence:",
"     </b>",
"     Sublingual tablet:",
"     <b>",
"      Note:",
"     </b>",
"     The combination product, buprenorphine and naloxone, is preferred therapy over buprenorphine monotherapy for induction treatment (and stabilization/maintenance treatment) for short-acting opioid dependence (U.S. Department of Health and Human Services, 2005).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Manufacturer's labeling:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Induction: Day 1: 8 mg; Day 2 and subsequent induction days: 16 mg; usual induction dosage range: 12-16 mg/day (induction usually accomplished over 3-4 days). Treatment should begin at least 4 hours after last use of heroin or other short-acting opioids, preferably when first signs of withdrawal appear. Titrating dose to clinical effectiveness should be done as rapidly as possible to prevent undue withdrawal symptoms and patient drop-out during the induction period. There is little controlled experience with induction in patients on methadone or other long-acting opioids; consult expert physician experienced with this procedure.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Maintenance: Target dose: 16 mg/day; in some patients 12 mg/day may be effective; patients should be switched to the buprenorphine/naloxone combination product for maintenance and unsupervised therapy",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F143080\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?25/29/26071?source=see_link\">",
"      see \"Buprenorphine: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Acute pain (moderate-to-severe):",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children 2-12 years:  I.M., slow I.V.: 2-6",
"     <b>",
"      mcg",
"     </b>",
"     /kg every 4-6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children &ge;13 years:  Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Opioid dependence:",
"     </b>",
"     Children &ge;16 years:  Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F143062\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Acute pain (moderate-to-severe):",
"     </b>",
"     I.M., slow I.V.: 0.15 mg every 6 hours; elderly patients are more likely to suffer from confusion and drowsiness compared to younger patients.",
"     <b>",
"      Long-term use is not recommended.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Chronic pain (moderate-to-severe):",
"     </b>",
"     Transdermal patch:  No specific dosage adjustments required; use caution due to potential for increased risk of adverse events.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15800558\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Injection, sublingual, transdermal: No dosage adjustment provided in manufacturer&rsquo;s labeling (has not been adequately studied); use with caution.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F11370826\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Injection: No dosage adjustment provided in manufacturer&rsquo;s labeling; undergoes extensive hepatic metabolism; use with caution, especially in severe impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Sublingual: Moderate-to-severe impairment: Dosage adjustments recommended; however, no specific recommendations are provided in the manufacturer's labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Transdermal patch:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Mild-to-moderate impairment: Initial: 5",
"     <b>",
"      mcg",
"     </b>",
"     /hour applied once every 7 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Severe impairment: Not studied; consider alternative therapy with more flexibility for dosing adjustments.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F143032\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution: 0.3 mg/mL (1 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Buprenex&reg;: 0.3 mg/mL (1 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution [preservative free]: 0.3 mg/mL (1 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Patch, transdermal:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Butrans&reg;: 5 mcg/hr (4s) [total buprenorphine 5 mg]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Butrans&reg;: 10 mcg/hr (4s) [total buprenorphine 10 mg]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Butrans&reg;: 20 mcg/hr (4s) [total buprenorphine 20 mg]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, sublingual: 2 mg, 8 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F143016\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Excludes patch",
"    </p>",
"   </div>",
"   <div class=\"block csi drugH1Div\" id=\"F143102\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Controlled Substance",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C-III",
"    </p>",
"   </div>",
"   <div class=\"block accres drugH1Div\" id=\"F11217368\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Prescribing and Access Restrictions",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     Prescribing of tablets for opioid dependence is limited to physicians who have met the qualification criteria and have received a DEA number specific to prescribing this product. Tablets will be available through pharmacies and wholesalers which normally provide controlled substances.",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F11370707\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and as follows, must be dispensed with this medication:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Butrans&trade;:",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/UCM219146.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/UCM219146.pdf",
"     </a>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Subutex&reg;:",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/UCM285300.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/UCM285300.pdf",
"     </a>",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F143035\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.M.: Administer via deep I.M. injection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V.: Administer slowly, over at least 2 minutes. Administration over 20-30 minutes preferred when managing opioid withdrawal in heroin-dependent hospitalized patients (Welsh, 2002).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: Sublingual tablet: Tablet should be placed under the tongue until dissolved; should not be swallowed. If two or more tablets are needed per dose, all may be placed under the tongue at once, or two at a time. To ensure consistent bioavailability, subsequent doses should always be taken the same way.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Transdermal patch: Apply to patch to intact, nonirritated skin only. Apply to a hairless or nearly hairless skin site. If hairless site is not available, do not shave skin; hair at application site should be clipped. Prior to application, if the site must be cleaned, clean with clear water and allow to dry completely; do not use soaps, alcohol, lotions or abrasives due to potential for increased skin absorption. Do not use any patch that has been damaged, cut or manipulated in any way. Remove patch from protective pouch immediately before application. Remove the protective backing, and apply the sticky side of the patch to one of eight possible application sites (upper outer arm, upper chest, upper back or the side of the chest [each site on either side of the body]). Firmly press patch in place and hold for ~15 seconds. Change patch every 7 days. Rotate patch application sites; wait &ge;21 days before reapplying another patch to the same skin site. Avoid exposing application site to external heat sources (eg, heating pad, electric blanket, heat lamp, hot tub). If there is difficulty with patch adhesion, the edges of the system may be taped in place with first-aid tape. If the patch falls off during the 7-day dosing interval, dispose of the patch and apply a new patch to a different skin site.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F143108\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Injection:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Acetaminophen, allopurinol, amifostine, aztreonam, cefepime, cisatracurium, cladribine, docetaxel, etoposide phosphate, filgrastim, gemcitabine, granisetron, linezolid, melphalan, oxaliplatin, pemetrexed, piperacillin/tazobactam, propofol, remifentanil, teniposide, thiotepa, vinorelbine.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Amphotericin B cholesteryl sulfate complex, doxorubicin liposome.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Compatible:",
"     </b>",
"     Bupivacaine, chlorpromazine, glycopyrrolate and haloperidol, heparin, midazolam.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F143033\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection: Management of moderate-to-severe pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Sublingual tablet: Treatment of opioid dependence",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Transdermal patch: Management of moderate-to-severe chronic pain in patients requiring an around-the-clock opioid analgesic for an extended period of time",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F11442184\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Injection: Management of opioid withdrawal in heroin-dependent hospitalized patients",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F143110\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Buprenex&reg; may be confused with Brevibloc&reg;, Bumex&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F143098\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Injection:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%: Central nervous system: Sedation (&le;66%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Hypotension (1% to 5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Dizziness/vertigo (5% to 10%), headache (1% to 5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Nausea (5% to 10%), vomiting (1% to 5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ocular: Miosis (1% to 5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Respiratory depression (1% to 5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Diaphoresis (1% to 5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1%: (Limited to important or life-threatening): Amblyopia, anaphylactic shock, apnea, bradycardia, conjunctivitis, coma, cyanosis, depersonalization, depression, diplopia, euphoria, hallucinations, hypersensitivity reactions, hypertension, injection site reaction, psychosis, seizures, slurred speech, tachycardia, urinary retention, Wenckebach block",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Tablet:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Headache (30%), pain (24%), insomnia (21% to 25%), anxiety (12%), depression (11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Nausea (10% to 14%), abdominal pain (12%), constipation (8% to 11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Back pain (14%), weakness (14%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Rhinitis (11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Withdrawal syndrome (18% to 22%; placebo 37%), infection (12% to 20%), diaphoresis (12% to 13%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Chills (6%), nervousness (6%), somnolence (5%), dizziness (4%), fever (3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Vomiting (5% to 8%), diarrhea (5%), dyspepsia (3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Abscess formation (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ocular: Lacrimation (5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Cough (4%), pharyngitis (4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Flu-like syndrome (6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Anaphylactic shock, angioedema, hepatic encephalopathy, hepatic failure, hepatic necrosis, hepatitis (including cytolytic), hepatorenal syndrome, hypersensitivity reactions, transaminases increased",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Transdermal patch:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Headache (3% to 14%), dizziness (2% to 15%), somnolence (2% to 13%),",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Nausea (6% to 23%), constipation (3% to 13%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Application site pruritus (4% to 15%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Chest pain (1% to &lt;5%), hypertension (1% to &lt;5%), peripheral edema (1% to &lt;5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Anxiety (1% to &lt;5%), depression (1% to &lt;5%), fatigue (1% to 5%), fever (1% to &lt;5%), hypoesthesia (1% to &lt;5%), insomnia (1% to &lt;5%), migraine (1% to &lt;5%), pain (1% to &lt;5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Hyperhydrosis (1% to &lt;5%), pruritus (1% to &lt;5%), rash (1% to &lt;5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Vomiting (4% to 9%), xerostomia (6%), anorexia (1% to &lt;5%), diarrhea (1% to &lt;5%), dyspepsia (1% to &lt;5%), upper abdominal pain (1% to &lt;5%), abdominal discomfort (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Urinary tract infection (1% to &lt;5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Application site erythema (3% to 10%), application site irritation (1% to 6%), application site rash (3% to 8%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia (1% to &lt;5%), back pain (1% to &lt;5%), joint swelling (1% to &lt;5%), muscle spasms (1% to &lt;5%), musculoskeletal pain (1% to &lt;5%), myalgia (1% to &lt;5%), neck pain (1% to &lt;5%), pain in extremity (1% to &lt;5%), paresthesia (1% to &lt;5%), tremor (1% to &lt;5%), weakness (1% to &lt;5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Bronchitis (1% to &lt;5%), cough (1% to &lt;5%), dyspnea (1% to &lt;5%), nasopharyngitis (1% to &lt;5%), pharyngolaryngeal pain (1% to &lt;5%), sinusitis (1% to &lt;5%), upper respiratory tract infection (1% to &lt;5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Flu-like syndrome (1% to &lt;5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): ALT increased, angina, angioedema, application site dermatitis, asthma exacerbation, bradycardia, contact dermatitis, diverticulitis, hallucinations, hyper/hypoventilation, hypersensitivity reactions, hypotension, ileus, loss of consciousness, memory impairment, mental impairment, mental status changes, miosis (dose-related), orthostatic hypotension, psychoses, respiratory depression, respiratory distress, respiratory failure, syncope, tachycardia, urinary incontinence, urinary retention, vasodilatation, visual disturbances, withdrawal syndrome",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F143038\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to buprenorphine or any component of the formulation",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Transdermal patch: Additional contraindications: Significant respiratory depression; acute or severe asthma; known or suspected paralytic ileus",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F143020\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS depression: May cause CNS depression, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic events: Hepatitis has been reported with buprenorphine use; hepatic events ranged from transient, asymptomatic transaminase elevations to hepatic failure; in many cases, patients had preexisting hepatic dysfunction. Monitor liver function tests in patients at increased risk for hepatotoxicity (eg, history of alcohol abuse, pre-existing hepatic dysfunction, I.V. drug abusers) prior to and during therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypersensitivity reactions: Hypersensitivity, including bronchospasm, angioneurotic edema, and anaphylactic shock, have been reported.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypotension: May cause hypotension; use with caution in patients with hypovolemia, cardiovascular disease (including acute MI), or drugs which may exaggerate hypotensive effects (including phenothiazines or general anesthetics).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; QT prolongation: Transdermal patch: Do not exceed one 20",
"     <b>",
"      mcg",
"     </b>",
"     /hour transdermal patch due to the risk of QT",
"     <sub>",
"      c",
"     </sub>",
"     -interval prolongation. Avoid using in patients with history of long QT syndrome or in patients with predisposing factors increasing the risk of QT abnormalities (eg, concurrent medications such as antiarrhythmics, hypokalemia, unstable heart failure, unstable atrial fibrillation).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Respiratory depression: Transdermal patch:",
"     <b>",
"      [U.S. Boxed Warning]: May cause potentially life-threatening respiratory depression even with therapeutic use. Ensure proper dosing and titration; monitor for respiratory depression, especially within the first 24-72 hours of initiation or dose escalation. Buprenorphine transdermal patches should only be prescribed by healthcare professionals familiar with the use of potent opioids for chronic pain.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Abdominal conditions: May obscure diagnosis or clinical course of patients with acute abdominal conditions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Adrenal insufficiency: Use with caution in patients with adrenal insufficiency, including Addison's disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Biliary tract impairment: Use with caution in patients with biliary tract dysfunction; acute pancreatitis may cause constriction of sphincter of Oddi.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bowel obstruction: Use with caution in patients with a history of ileus or bowel obstruction; use of transdermal patch is contraindicated in patients with known or suspected paralytic ileus.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS depression/coma: Use with caution in patients with CNS depression or coma.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Head trauma: Use with extreme caution in patients with head injury, intracranial lesions, or elevated intracranial pressure; exaggerated elevation of ICP may occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment. Dosage adjustments are recommended in hepatic impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Obesity: Use with caution in patients who are morbidly obese.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Prostatic hyperplasia/urinary stricture: Use with caution in patients with prostatic hyperplasia and/or urinary stricture.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Psychosis: Use with caution in patients with toxic psychosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Respiratory disease: Use with extreme caution in patients with pre-existing respiratory compromise (hypoxia and/or hypercapnia), COPD or other obstructive pulmonary disease, and kyphoscoliosis or other skeletal disorder which may alter respiratory function; critical respiratory depression may occur, even at therapeutic dosages.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizure: Opioid therapy may lower seizure threshold; use caution in patients with a history of seizure disorders.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thyroid dysfunction: Use with caution in patients with thyroid dysfunction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sedatives: Effects may be potentiated when used with other sedative drugs or ethanol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Debilitated patients: Use with caution in debilitated or cachectic patients; there is a greater potential for critical respiratory depression, even at therapeutic dosages.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Use with caution in the elderly; may be more sensitive to adverse effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Transdermal patch: Indicated for the management of chronic moderate-to-severe pain when around the clock pain control is needed for an extended time period; should not be used for as-needed pain relief or for the treatment of mild pain, acute pain, or postoperative pain requiring short-term opioid analgesia.",
"     <b>",
"      [U.S. Boxed Warning]: Proper storage, handling, and disposal of used patches are essential to prevent accidental exposures, especially in children; accidental exposure may result in a fatal overdose.",
"     </b>",
"     To properly dispose of Butrans&reg; patch, fold it over on itself and flush down the toilet; alternatively, seal the used patch in the provided Patch-Disposal Unit and dispose of in the trash.  Avoid exposure of application site and surrounding area to direct external heat sources. Buprenorphine release from the patch is temperature-dependent and may result in overdose. Patients who experience fever or increase in core temperature should be monitored closely.  Application site reactions, including rare cases of severe reactions (eg, vesicles, discharge,&ldquo;burns&rdquo;), have been observed with use; onset varies from days to months after initiation; patients should be instructed to report severe reactions promptly. Therapy with the transdermal patch is not appropriate for use in the management of addictions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Abuse/misuse/diversion: Transdermal patch:",
"     <b>",
"      [U.S. Boxed Warning]: Healthcare provider should be alert to problems of abuse, misuse, and diversion.",
"     </b>",
"     Risk of opioid abuse is increased in patients with a history or family history of alcohol or drug abuse or mental illness.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Optimal pain regimen: An opioid-containing analgesic regimen should be tailored to each patient's needs and based upon the type of pain being treated (acute versus chronic), the route of administration, degree of tolerance for opioids (naive versus chronic user), age, weight, and medical condition. The optimal analgesic dose varies widely among patients; doses should be titrated to pain relief/prevention.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Withdrawal: Concurrent use of agonist/antagonist analgesics may precipitate withdrawal symptoms and/or reduced analgesic efficacy  in patients following prolonged therapy with mu opioid agonists. Abrupt discontinuation following prolonged use may also lead to withdrawal symptoms and is not recommended; taper dose gradually when discontinuing. Tablets, which are used for induction treatment of opioid dependence, should not be started until effects of withdrawal are evident.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F143094\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP3A4 (major);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP1A2 (weak), CYP2A6 (weak), CYP2C19 (weak), CYP2D6 (weak)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F143025\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): May enhance the CNS depressant effect of Buprenorphine. Management: Advise patients receiving buprenorphine about the increased risk of CNS depression if they consume alcohol.  Consider alternatives to buprenorphine for opioid addiction treatment in patients who are dependent on alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alvimopan: Analgesics (Opioid) may enhance the adverse/toxic effect of Alvimopan. This is most notable for patients receiving long-term (i.e., more than 7 days) opiates prior to alvimopan initiation.  Management: Alvimopan is contraindicated in patients receiving therapeutic doses of opioids for more than 7 consecutive days immediately prior to alvimopan initiation.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ammonium Chloride: May increase the excretion of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: May enhance the analgesic effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Analgesics (Opioid): Mixed Agonist / Antagonist Opioids may diminish the analgesic effect of Analgesics (Opioid).  Management: Seek alternatives to mixed agonist/antagonist opioids in patients receiving pure opioid agonists, and monitor for symptoms of therapeutic failure/high dose requirements (or withdrawal in opioid-dependent patients) if patients receive these combinations.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antipsychotic Agents (Phenothiazines): May enhance the hypotensive effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP2D6 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Atazanavir: May increase the serum concentration of Buprenorphine. Buprenorphine may decrease the serum concentration of Atazanavir. Management: Avoid this combination in patients un-boosted atazanavir due to possible decreased atazanavir concentrations.  This combination is not contraindicated in patients also receiving ritonavir, but monitoring for buprenorphine toxicity is recommended.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Boceprevir: May decrease the serum concentration of Buprenorphine. Boceprevir may increase the serum concentration of Buprenorphine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the CNS depressant effect of Buprenorphine. Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Conivaptan: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May increase the metabolism of CYP3A4 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Moderate): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Strong): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Desmopressin: Analgesics (Opioid) may enhance the adverse/toxic effect of Desmopressin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Efavirenz: May decrease serum concentrations of the active metabolite(s) of Buprenorphine. Efavirenz may decrease the serum concentration of Buprenorphine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Etravirine: May decrease the serum concentration of Buprenorphine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (CYP3A4 Inducers): May increase the metabolism of CYP3A4 Substrates. Management: Consider avoiding CYP3A4 inducing herbs in order to avoid therapeutic failure of the substrate. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: Buprenorphine may enhance the adverse/toxic effect of MAO Inhibitors.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May increase the serum concentration of CYP3A4 Substrates. Management: Minimize doses of CYP3A4 substrates, and monitor for increased concentrations/toxicity, during and 2 weeks following treatment with mifepristone. Avoid cyclosporine, dihydroergotamine, ergotamine, fentanyl, pimozide, quinidine, sirolimus, and tacrolimus.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mixed Agonist / Antagonist Opioids: May diminish the analgesic effect of Analgesics (Opioid). Management: Seek alternatives to mixed agonist/antagonist opioids in patients receiving pure opioid agonists, and monitor for symptoms of therapeutic failure/high dose requirements (or withdrawal in opioid-dependent patients) if patients receive these combinations.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pegvisomant: Analgesics (Opioid) may diminish the therapeutic effect of Pegvisomant.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: Analgesics (Opioid) may enhance the serotonergic effect of Selective Serotonin Reuptake Inhibitors. This may cause serotonin syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Succinylcholine: May enhance the bradycardic effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: Analgesics (Opioid) may enhance the orthostatic hypotensive effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F143052\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: May increase CNS depression; monitor for increased effects with coadministration. Caution patients about effect.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Herb/Nutraceutical: Avoid valerian, St John's wort, kava kava, gotu kola (may increase CNS depression).",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F143027\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F143041\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse effects have been observed in animal reproduction studies following buprenorphine subcutaneous and transdermal administration. In humans, withdrawal has been reported in infants of women receiving buprenorphine during pregnancy. Onset of symptoms ranged from day 1 to day 8 of life, most occurring on day 1.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F143067\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F5989198\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Patch weekly",
"     </b>",
"     (Butrans Transdermal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mcg/hr (4): $176.30",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mcg/hr (4): $264.44",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mcg/hr (4): $468.18",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Buprenex Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.3 mg/mL (1 mL): $12.10",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Buprenorphine HCl Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.3 mg/mL (1 mL): $3.36",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Sublingual",
"     </b>",
"     (Buprenorphine HCl Sublingual)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2 mg (30): $124.20",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     8 mg (30): $232.20",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F143029\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Pain relief, respiratory and mental status, CNS depression, blood pressure; LFTs (prior to initiation and during therapy); symptoms of withdrawal; application site reactions (transdermal patch)",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F143042\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Brospina (MX);",
"     </li>",
"     <li>",
"      Buprine (TH);",
"     </li>",
"     <li>",
"      Butrans (GB, IE, IL);",
"     </li>",
"     <li>",
"      Nopan (IL);",
"     </li>",
"     <li>",
"      Norphin (IN);",
"     </li>",
"     <li>",
"      Norspan Patch (AU, CZ, DK, EE, FI, KP, NO, NZ, PH);",
"     </li>",
"     <li>",
"      Pentorel (IN);",
"     </li>",
"     <li>",
"      SBT (IL);",
"     </li>",
"     <li>",
"      Shumeifen (CL);",
"     </li>",
"     <li>",
"      Sovenor (MY);",
"     </li>",
"     <li>",
"      Subutex (AT, AU, BE, BG, CH, CZ, DE, DK, EE, FI, FR, ID, IE, IL, NO, PT, SE, SG, TW);",
"     </li>",
"     <li>",
"      Temgesic (AE, AR, AT, BE, BF, BH, BJ, BR, CH, CI, CY, CZ, DE, DK, EE, EG, ES, ET, FI, FR, GB, GH, GM, GN, GR, HK, IQ, IR, IT, JO, KE, KW, LB, LR, LU, LY, MA, ML, MR, MT, MU, MW, MX, NE, NG, NL, NO, NZ, OM, PK, PL, QA, RU, SA, SC, SD, SE, SG, SK, SL, SN, SY, TH, TN, TR, TW, TZ, UG, YE, ZA, ZM, ZW);",
"     </li>",
"     <li>",
"      Tidigesic (IN);",
"     </li>",
"     <li>",
"      Transtec (CH, CN, CO, DE, EC, ES, GB, HN, IE, MX, PE, PT)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F143019\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Buprenorphine exerts its analgesic effect via high affinity binding to &mu; opiate receptors in the CNS; displays partial mu agonist and weak kappa antagonist activity",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F143037\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Analgesic: I.M: Within 15 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Peak effect: I.M.: ~1 hour; Transdermal patch: Steady state achieved by day 3",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: I.M.: &ge;6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: I.M., SubQ: 30% to 40%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 97-187 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: High (~96%, primarily to alpha- and beta globulin)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Primarily hepatic via N-dealkylation by CYP3A4 to norbuprenorphine (active metabolite), and to a lesser extent via glucuronidation by UGT1A1 and 2B7 to buprenorphine 3-O-glucuronide; the major metabolite, norbuprenorphine, also undergoes glucuronidation via UGT1A3; extensive first-pass effect",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability (relative to I.V. administration): I.M.: 70%; Sublingual tablet: 29%; Transdermal patch: ~15%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: I.V.: 2.2-3 hours; Apparent terminal half-life: Sublingual tablet: ~37 hours; Transdermal patch: ~26 hours.",
"     <b>",
"      Note:",
"     </b>",
"     Extended elimination half-life for sublingual administration may be due to depot effect (Kuhlman, 1996).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, plasma: Sublingual: 30 minutes to 1 hour (Kuhlman, 1996)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Feces (~70%); urine (27% to 30%)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Center for Substance Abuse Treatment,",
"      <i>",
"       Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction",
"      </i>",
"      , Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04���3939. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2004",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Drugs for Pain,&rdquo;",
"      <i>",
"       Med Lett Drugs Ther",
"      </i>",
"      , 2000, 42(1085):73-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/53/41816/abstract-text/10951654/pubmed\" id=\"10951654\" target=\"_blank\">",
"        10951654",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gal TJ, &ldquo;Naloxone Reversal of Buprenorphine-Induced Respiratory Depression,&rdquo;",
"      <i>",
"       Clin Pharmacol Ther",
"      </i>",
"      , 1989, 45(1):66-71.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/53/41816/abstract-text/2491980/pubmed\" id=\"2491980\" target=\"_blank\">",
"        2491980",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Harcus AH, Ward AE, and Smith DW, &ldquo;Buprenorphine: Experience in an Elderly Population of 975 Patients During a Year's Monitored Release,&rdquo;",
"      <i>",
"       Br J Clin Pract",
"      </i>",
"      , 1980, 34(5):144-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/53/41816/abstract-text/7407029/pubmed\" id=\"7407029\" target=\"_blank\">",
"        7407029",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Jain PN and Shah SC, &ldquo;Respiratory Depression Following Combination of Epidural Buprenorphine and Intramuscular Ketorolac,&rdquo;",
"      <i>",
"       Anaesthesia",
"      </i>",
"      , 1993, 48(10):898-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/53/41816/abstract-text/8238835/pubmed\" id=\"8238835\" target=\"_blank\">",
"        8238835",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kuhlman JJ Jr, Lalani S, Magluilo J Jr, et al, &ldquo;Human Pharmacokinetics of Intravenous, Sublingual and Buccal Buprenorphine,&rdquo;",
"      <i>",
"       J Anal Toxicol",
"      </i>",
"      , 1996, 20(6):369-78.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/53/41816/abstract-text/8889672/pubmed\" id=\"8889672\" target=\"_blank\">",
"        8889672",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      MacEvilly M and O'Carroll C, &ldquo;Hallucinations After Epidural Buprenorphine,&rdquo;",
"      <i>",
"       Br Med J",
"      </i>",
"      , 1989, 298(6678):928-9.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mokhlesi B, Leikin JB, Murray P, et al, &ldquo;Adult Toxicology in Critical Care: Part II: Specific Poisonings,&rdquo;",
"      <i>",
"       Chest",
"      </i>",
"      , 2003, 123(3):897-922.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/53/41816/abstract-text/12628894/pubmed\" id=\"12628894\" target=\"_blank\">",
"        12628894",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain,&rdquo; 6th ed, Glenview, IL: American Pain Society, 2008.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sporer KA, &ldquo;Buprenorphine: A Primer for Emergency Physicians,&rdquo;",
"      <i>",
"       Ann Emerg Med",
"      </i>",
"      , 2004, 43(5):580-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/53/41816/abstract-text/15111917/pubmed\" id=\"15111917\" target=\"_blank\">",
"        15111917",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Welsh CJ, Suman M, Cohen A, et al, &ldquo;The Use of Intravenous Buprenorphine for the Treatment of Opioid Withdrawal in Medically Ill Hospitalized Patients,&rdquo;",
"      <i>",
"       Am J Addict",
"      </i>",
"      , 2002, 11(2): 135-40.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/53/41816/abstract-text/12028743/pubmed\" id=\"12028743\" target=\"_blank\">",
"        12028743",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9170 Version 49.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-190.92.87.104-A2ED1F3088-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_53_41816=[""].join("\n");
var outline_f40_53_41816=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11370705\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143056\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143057\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143100\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143061\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143080\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143062\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15800558\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11370826\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143032\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143016\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143102\">",
"      Controlled Substance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11217368\">",
"      Prescribing and Access Restrictions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11370707\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143035\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143108\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143033\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11442184\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143110\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143098\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143038\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143020\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143094\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143025\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143052\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143027\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143041\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143067\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5989198\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143029\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143042\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143019\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143037\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9170\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9170|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?42/30/43494?source=related_link\">",
"      Buprenorphine: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?25/29/26071?source=related_link\">",
"      Buprenorphine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_53_41817="Radiofrequency ablation for Barrett's esophagus";
var content_f40_53_41817=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Radiofrequency ablation for Barrett's esophagus",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/53/41817/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/53/41817/contributors\">",
"     Jacques J Bergman, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/53/41817/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/53/41817/contributors\">",
"     John R Saltzman, MD, FACP, FACG, FASGE",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/53/41817/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/53/41817/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/53/41817/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 13, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Barrett's esophagus (BE) occurs when an abnormal, intestinal-type epithelium called \"specialized intestinal metaplasia\" replaces the stratified squamous epithelium that normally lines the distal esophagus. The condition develops as a consequence of chronic gastroesophageal reflux disease and predisposes to the development of adenocarcinoma of the esophagus.",
"   </p>",
"   <p>",
"    Traditionally, high-grade dysplasia and intramucosal cancer arising from BE were treated with esophagectomy, while non-dysplastic BE and BE with low-grade dysplasia were managed with endoscopic surveillance. Problems associated with these approaches included significant morbidity and mortality from esophagectomy, and the risk of missed or interval development of cancer in patients undergoing surveillance. To address these issues, less invasive endoscopic treatments have been developed.",
"   </p>",
"   <p>",
"    Radiofrequency ablation is a promising endoscopic treatment modality for BE. Primary circumferential ablation is performed using a balloon-based bipolar electrode, while secondary treatment of residual BE is performed using an endoscope-mounted bipolar electrode on an articulated platform. Studies suggest that this ablation technique is highly effective in removing Barrett's mucosa and associated dysplasia, while minimizing the known drawbacks of photodynamic therapy and argon plasma coagulation such as esophageal stenosis and subsquamous foci of BE (\"buried Barrett's\").",
"   </p>",
"   <p>",
"    This topic will review the use of radiofrequency ablation for the treatment of Barrett's esophagus. Other issues related to Barrett's esophagus, including alternative treatments, are discussed separately.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/8/1161?source=see_link\">",
"       \"Epidemiology, clinical manifestations, and diagnosis of Barrett's esophagus\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/12/8391?source=see_link\">",
"       \"Pathogenesis of Barrett's esophagus and its malignant transformation\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/40/29316?source=see_link\">",
"       \"Narrow band imaging in Barrett's esophagus\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/0/15370?source=see_link\">",
"       \"Chromoendoscopy\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?13/27/13750?source=see_link\">",
"       \"Autofluorescence endoscopy for Barrett's esophagus\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/61/35802?source=see_link\">",
"       \"Management of Barrett's esophagus\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/27/26039?source=see_link\">",
"       \"Photodynamic therapy for ablation of Barrett's esophagus\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?10/38/10858?source=see_link\">",
"       \"Endoscopic resection for treatment of high-grade dysplasia and early cancer in Barrett's esophagus\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR RFA",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Visible lesions containing high-grade dysplasia or intramucosal carcinoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with visible abnormalities in a segment of Barrett's esophagus (BE) that contains intramucosal carcinoma (IMC) or high-grade dysplasia (HGD) may be treated with radiofrequency ablation (RFA), but only after endoscopic mucosal resection (EMR) of the IMC or visible lesion. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/38/10858?source=see_link\">",
"     \"Endoscopic resection for treatment of high-grade dysplasia and early cancer in Barrett's esophagus\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H15\">",
"     'Combining endoscopic mucosal resection and RFA for high-grade dysplasia and intramucosal carcinoma'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    EMR provides a relatively large tissue specimen that allows for histopathological staging of a lesion, enabling the selection of patients for endoscopic treatment who have HGD or IMC and a low risk of lymph node involvement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. Patients found to have submucosal invading lesions on histology have a 15 to 30 percent risk of positive local lymph nodes and should be referred for surgery. On the other hand, the risk of lymph node involvement is minimal in patients with IMC, making these patients candidates for endoscopic management [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/4,5\">",
"     4,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A reason for combining ablative therapy with EMR is that EMR only removes a focal area from the BE, leaving the patient at risk for metachronous lesions arising from the residual Barrett's mucosa [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/6\">",
"     6",
"    </a>",
"    ]. The addition of ablative therapy to EMR helps overcome this limitation.",
"   </p>",
"   <p>",
"    In addition to staging a lesion, EMR is also done prior to RFA to provide a flat mucosa for RFA, which helps ensure that the ablation reaches the muscularis mucosae (",
"    <a class=\"graphic graphic_picture graphicRef54979 \" href=\"mobipreview.htm?23/40/24198\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Flat high-grade dysplasia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Barrett's patients with HGD seem to be ideal candidates for RFA since successful eradication of their dysplastic BE prevents the development of cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/7\">",
"     7",
"    </a>",
"    ]. However, proper patient selection is critical. Patients should have no visible lesions, as these require endoscopic mucosal resection (EMR) for optimal staging and treatment.",
"   </p>",
"   <p>",
"    To ensure that only patients with flat HGD are being treated with RFA monotherapy, several studies have required that patients undergo at least two high-resolution endoscopies with four-quadrant biopsies every 1 to 2 cm within two months prior to RFA to exclude cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/1,2,8\">",
"     1,2,8",
"    </a>",
"    ]. No studies have yet evaluated the use of RFA for flat intramucosal carcinoma (IMC).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Low-grade dysplasia",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several arguments that favor the use of RFA for low-grade dysplasia (LGD) in BE:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A confirmed histological diagnosis of LGD in BE represents a cancer-cell phenotype confined to the epithelium of the esophagus. For this reason, the World Health Organization has advised replacing the term \"LGD\" with the term \"low-grade intraepithelial neoplasia\". The risk of neoplastic progression associated with dysplastic BE is high. In one study, patients with a consensus diagnosis of LGD had an 85 percent cumulative risk of progressing to high-grade dysplasia (HGD) during follow-up, with an annual incidence of 13.4 percent per patient per year [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/9\">",
"       9",
"      </a>",
"      ]. However, it is important to note that in the presence of inflammation, making an accurate diagnosis of LGD can be difficult; thus, RFA should only be considered in cases of confirmed LGD.",
"     </li>",
"     <li>",
"      Endoscopic biopsy sampling errors and inter-observer discordance between pathologists may erroneously downgrade a patient from HGD to LGD. Treatment ensures that all neoplastic cells are eradicated.",
"     </li>",
"     <li>",
"      Cost-utility models show that ablation is the preferred strategy for managing dysplastic BE over a wide range of conservative assumptions related to the efficacy of RFA. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Cost-effectiveness'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Given these considerations, many experts believe that the net health benefit (benefit minus risk) of RFA for dysplastic BE is favorable, and thus RFA should be available to patients as a primary treatment option. Our practice is to enroll these patients in randomized trials. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/61/35802?source=see_link&amp;anchor=H73510534#H73510534\">",
"     \"Management of Barrett's esophagus\", section on 'Endoscopic treatment of low-grade dysplasia and nondysplastic Barrett's esophagus'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Non-dysplastic BE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of progression to cancer in patients with non-dysplastic Barrett's esophagus (BE) is small, and no objective markers are available to identify patients with an increased risk of developing cancer, though research looking at the risk-stratification of non-dysplastic BE has shown promising results. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/61/35802?source=see_link&amp;anchor=H7#H7\">",
"     \"Management of Barrett's esophagus\", section on 'Influence of Barrett's esophagus on mortality'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/12/8391?source=see_link\">",
"     \"Pathogenesis of Barrett's esophagus and its malignant transformation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Evidence from a number of well-designed studies, including a randomized, sham-controlled trial, suggests that radiofrequency ablation (RFA) is highly effective at removing all Barrett's mucosa (endoscopically and histologically) with a favorable safety profile. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Efficacy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Whether to offer RFA to patients with non-dysplastic BE is highly controversial and is influenced by many factors. An argument against RFA in these patients is that the annual risk of malignant progression is low, and many patients with BE are elderly with significant comorbid illnesses that limit their life-expectancy. Factors that favor treatment include the efficacy and safety profile of RFA and potential cost savings. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/12/8391?source=see_link\">",
"     \"Pathogenesis of Barrett's esophagus and its malignant transformation\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H12\">",
"     'Efficacy'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H21\">",
"     'Adverse events'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H23\">",
"     'Cost-effectiveness'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    For most patients with non-dysplastic BE, the net health benefit of RFA may be too low to justify its use. However, RFA should be considered for selected patients (eg, &lt; 50 years and a positive family history for esophageal adenocarcinoma).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     ABLATION PROCEDURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiofrequency ablation (RFA) of Barrett's esophagus (BE) generally starts with a stepwise circumferential ablation procedure, followed by focal ablation for any residual BE (",
"    <a class=\"graphic graphic_figure graphicRef61557 \" href=\"mobipreview.htm?20/51/21304\">",
"     figure 1",
"    </a>",
"    ). RFA is performed using the HALO system (B&Acirc;RRX Medical, Sunnyvale, California), which is comprised of two distinct ablation systems: the HALO360 system for primary circumferential RFA and the HALO90 system for secondary focal RFA of BE.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Circumferential ablation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Circumferential RFA with the HALO360 system involves the inflation of a balloon ablation catheter within the esophagus at the site of the BE. The ablation catheter includes a coiled electrode array through which an electric current is applied, ablating the Barrett's mucosa (",
"    <a class=\"graphic graphic_picture graphicRef69757 \" href=\"mobipreview.htm?9/60/10181\">",
"     picture 2",
"    </a>",
"    ). Two applications of RF energy at 10 or 12",
"    <span class=\"nowrap\">",
"     J/cm2",
"    </span>",
"    is the most effective regimen for circumferential ablation of the full thickness of the epithelium without injuring the submucosa [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/10-12\">",
"     10-12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Landmark determination &mdash; The first step in circumferential ablation is spraying the esophageal wall with 1 percent",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?20/1/20504?source=see_link\">",
"       acetylcysteine",
"      </a>",
"      and then flushing it with water to remove excessive mucus. Next, the top of the gastric folds and the proximal extent of the BE (including islands) are recorded for reference during the sizing and ablation procedures. A stiff guide-wire or metal wire is then introduced, and the endoscope is removed, leaving the guide-wire in place.",
"     </li>",
"     <li>",
"      Esophageal sizing &mdash; Once the guide-wire is in place, a sizing catheter is connected to the HALO360 generator, calibrated, and introduced over the guide-wire. The sizing catheter is used to measure the inner esophageal diameter prior to circumferential ablation. It consists of a 165-cm long shaft with 1-cm markings and a clear, 4-cm long non-compliant balloon at its distal end (",
"      <a class=\"graphic graphic_picture graphicRef82456 \" href=\"mobipreview.htm?19/50/20271\">",
"       picture 3",
"      </a>",
"      ). Upon activation via a footswitch, the sizing balloon is inflated to 4.3 psi (0.30 atm) by the generator using an integrated pressure:volume system. Based upon the baseline balloon volume and geometry, the mean esophageal inner diameter is calculated along the entire length of the 4-cm long balloon.",
"      <br/>",
"      <br/>",
"      The sizing procedure can be performed as a \"blind\" procedure, using the 1-cm scale on the catheter shaft for reference. For the first measurement, the catheter is placed so that the distal end of the balloon is 1 cm above the proximal extent of the Barrett's mucosa. After the first measurement cycle, the catheter is advanced 1 cm, and the process is repeated. This sequence is reiterated until an increase in measured diameter indicates the transition into a hiatal hernia or the stomach.",
"     </li>",
"     <li>",
"      Ablation catheter selection &mdash; Based on the esophageal inner diameter measurements, an appropriate HALO360+ ablation catheter is selected. The HALO360+ ablation catheter consists of a 165-cm long shaft with a balloon at its distal end that contains a 3-cm long bipolar electrode. The electrode contains 60 electrode rings that alternate in polarity and completely encircle the balloon (",
"      <a class=\"graphic graphic_figure graphicRef59355 \" href=\"mobipreview.htm?17/13/17631\">",
"       figure 2",
"      </a>",
"      ). The ablation catheter is available in five outer diameters (18, 22, 25, 28, and 31 mm once inflated).",
"      <br/>",
"      <br/>",
"      The outer diameter of the ablation balloon should be smaller than the narrowest measured esophageal diameter. In patients who underwent prior EMR, the ablation catheter should be selected conservatively, keeping in mind that the sizing balloon calculates a mean inner diameter over a length of 4 cm, which might result in an overestimation of the esophageal inner diameter at the site of an EMR scar. For example, if the smallest measured diameter is 30 mm, a 28-mm balloon would be appropriate in a patient who had not undergone EMR, whereas a 25-mm balloon would be chosen for a patient who had undergone EMR [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/2\">",
"       2",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Combining endoscopic mucosal resection and RFA for high-grade dysplasia and intramucosal carcinoma'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      First circumferential ablation &mdash; The ablation catheter is introduced over the guide-wire, followed by the endoscope, which is advanced alongside the ablation catheter. Under endoscopic visualization, the proximal margin of the electrode is placed 1 cm above the most proximal extent of the BE.",
"      <br/>",
"      <br/>",
"      The ablation catheter is then inflated to 4.3 psi (0.30 atm). Upon activation, radiofrequency (RF) energy is delivered to the electrode. Energy delivery typically lasts less than 1.5 seconds, after which the balloon automatically deflates. Moving distally, the balloon is repositioned, allowing a small amount of overlap with the previous ablation zone (5 to 10 mm). Ablation is repeated until the entire length of BE has received one application of radiofrequency energy. We treat the entire BE segment in a single session. However, if the patient is elderly and frail we use a conservative approach for BE segments longer than12 cm, treating the segment in two sessions.",
"     </li>",
"     <li>",
"      Cleaning between ablation cycles &mdash; After the entire length of BE has undergone one ablation cycle, the guide-wire, ablation catheter, and endoscope are removed. Once outside the patient, the catheter is inflated and any adherent coagulum on the electrode surface is removed using wet gauze.",
"      <br/>",
"      <br/>",
"      A soft distal attachment cap is then fitted on the tip of the endoscope, and the scope is reintroduced into the patient. The soft extending rim of the cap is used to gently slough off the coagulum from the esophageal wall in the ablation zone. After most of the coagulum has been removed with the cap, forceful spraying of water through a spraying catheter using a high-pressure pistol can be used to wash off residual coagulum. Although the cleaning procedure requires extra procedure time, studies suggest that it increases the efficacy of the ablation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/1,2,13\">",
"       1,2,13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Second circumferential ablation &mdash; After the cleaning procedure, the entire length of BE is ablated again using the same energy settings. A circumferential ablation treatment using the HALO360 system takes approximately 30 to 40 minutes, depending upon the length of the BE.",
"     </li>",
"     <li>",
"      Follow-up circumferential ablation &mdash; Twelve weeks after the first circumferential ablation treatment, patients undergo a follow-up endoscopy, and additional therapy is carried out if needed. A",
"      <strong>",
"       circumferential",
"      </strong>",
"      &nbsp;",
"      <strong>",
"       ablation",
"      </strong>",
"      is performed if:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      There is residual circumferential BE measuring 2 cm or more",
"     </li>",
"     <li>",
"      There are multiple islands or tongues of BE",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Follow-up focal ablation &ndash; At the 12-week follow-up endoscopy, patients are treated with secondary",
"      <strong>",
"       focal",
"      </strong>",
"      &nbsp;",
"      <strong>",
"       ablation",
"      </strong>",
"      using the HALO90 system if:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      There is an irregular Z-line",
"     </li>",
"     <li>",
"      There are small tongues of BE",
"     </li>",
"     <li>",
"      There is residual BE with a circumferential extent of less than 2 cm",
"     </li>",
"     <li>",
"      There are scattered islands of BE",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Focal ablation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Focal RFA with the HALO90 system also uses electric energy to ablate small areas of BE. For focal ablation, the electric current is delivered through an electrode array attached to the end of the endoscope (",
"    <a class=\"graphic graphic_picture graphicRef79660 \" href=\"mobipreview.htm?30/33/31252\">",
"     picture 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The electrode array is mounted on an articulated platform (",
"    <a class=\"graphic graphic_figure graphicRef72263 \" href=\"mobipreview.htm?37/54/38767\">",
"     figure 3",
"    </a>",
"    ), allowing the electrode to move front-to-back and left-to-right, ensuring optimal tissue contact. It can be attached with a flexible strap to the distal end of any endoscope with a diameter of 8.6 mm to 12.8 mm without impairing endoscopic view or function. The electrode array is 20.6 mm long and 13.2 mm wide with an active electrode-surface of 20 mm x 13 mm.",
"   </p>",
"   <p>",
"    In addition to the endoscope-mounted electrode array, the HALO90 system also uses an energy generator similar to the HALO360 generator, but without the pressure:volume system.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Electrode&nbsp;introduction &mdash; The HALO90 electrode array fits on the tip of the endoscope and is placed at the 12 o'clock position in the endoscopic video image. The device and endoscope are then introduced under visual guidance. When the laryngeal cavity is seen, the tip of the endoscope is deflected slightly downward, allowing the leading edge of the catheter to pass behind the arytenoids. The patient is then asked to swallow, and the endoscope is gently advanced.",
"      <br/>",
"      <br/>",
"      In about 10 percent of cases, introducing the electrode array may prove difficult. In those cases, a Zenker's diverticulum should be excluded. Introduction of the device should never be forced due to the risk of perforation. In these cases, we will sometimes blindly pass a biopsy forceps or the spraying catheter into the esophagus to guide the endoscope into the proximal esophagus. In difficult cases, a CRE-balloon may be used to open the upper esophageal sphincter by manually inflating the balloon to a low pressure and then advancing the endoscope and HALO90 device along with the balloon.",
"     </li>",
"     <li>",
"      First focal ablation &mdash; Residual Barrett's epithelium is positioned at the 12 o'clock position in the endoscopic video image, corresponding to the position of the electrode. The electrode is brought into close contact with the mucosa, deflected upward, and activated.",
"      <br/>",
"      <br/>",
"      Without separating the electrode from the esophageal wall, the electrode array is immediately activated a second time, resulting in a \"double\" application of energy. In addition to treatment of any visually apparent BE, ablation of the entire Z-line is recommended (even if no clear tongues of BE are observed) to ensure eradication of all BE at the gastroesophageal junction (",
"      <a class=\"graphic graphic_picture graphicRef82128 \" href=\"mobipreview.htm?15/52/16196\">",
"       picture 5",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Cleaning procedure &mdash; After all residual BE has been ablated, the coagulum is carefully pushed off the esophageal wall with the leading edge of the electrode array. The electrode surface is then cleaned outside the patient. Finally, the ablation zone in the esophagus is rinsed with a spraying catheter and pressure pistol, as described above. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Circumferential ablation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Second focal ablation &mdash; Using the ablation zones from the first ablation pass as a guide, all ablated areas are treated with a second \"double\" application of energy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Post-treatment care",
"    </span>",
"    &nbsp;&mdash;&nbsp;After RFA, acid suppressant therapy is important, not only to minimize patient discomfort, but also to allow the esophagus to heal optimally and regenerate with squamous epithelium. Studies suggest that ongoing gastroesophageal reflux has an adverse effect on treatment outcome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. All patients should, therefore, receive high-dose proton pump inhibitors as maintenance therapy. In addition, extra acid suppression after each treatment session is advisable. We prescribe all patients",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/39/15993?source=see_link\">",
"     esomeprazole",
"    </a>",
"    40 mg twice per day, supplemented with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/56/42888?source=see_link\">",
"     ranitidine",
"    </a>",
"    300 mg at bedtime, and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/29/29141?source=see_link\">",
"     sucralfate",
"    </a>",
"    suspension (200",
"    <span class=\"nowrap\">",
"     mg/mL)",
"    </span>",
"    5 mL four times a day for two weeks after each ablation session [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. The proton pump inhibitor is then continued for maintenance therapy.",
"   </p>",
"   <p>",
"    After RFA, patients should adhere to a liquid diet for 24 hours. After 24 hours, patients may gradually advance to a soft and then normal diet at their own discretion, generally guided by their symptoms. Patients may experience symptoms of chest discomfort, sore throat, difficulty or pain with swallowing,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    nausea, which usually improve daily.",
"   </p>",
"   <p>",
"    For patients who have pain following the procedure,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    500 to 1000 mg up to four times per day may be given as needed. Acetaminophen can be supplemented with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/29/38352?source=see_link\">",
"     diclofenac",
"    </a>",
"    50 mg up to twice daily if the acetaminophen does not provide adequate relief. Other analgesic regimens include an",
"    <span class=\"nowrap\">",
"     antacid/",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?34/34/35360?source=see_link\">",
"      lidocaine",
"     </a>",
"    </span>",
"    slurry and liquid acetaminophen with or without",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/0/35848?source=see_link\">",
"     codeine",
"    </a>",
"    . Some patients may also require an antiemetic medication.",
"   </p>",
"   <p>",
"    For patients presenting with severe chest pain and fever following their procedures, observation and conservative management with maximal acid suppression and an analgesic regimen will usually suffice. Only in rare cases when there is a clear suspicion of severe complications is additional testing (eg, computed tomography) required.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Follow-up endoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two months after the last treatment, the absence of residual Barrett's epithelium should be confirmed by endoscopic inspection. Techniques available to detect residual BE include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Use of high-resolution endoscopes with Lugol's stain (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/0/15370?source=see_link&amp;anchor=H4#H4\">",
"       \"Chromoendoscopy\", section on 'Lugol's solution'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Narrow band imaging or comparable technology (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/40/29316?source=see_link\">",
"       \"Narrow band imaging in Barrett's esophagus\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is important to detect even small areas of BE, as any residual BE puts the patient at risk of developing esophageal adenocarcinoma (",
"    <a class=\"graphic graphic_picture graphicRef79660 \" href=\"mobipreview.htm?30/33/31252\">",
"     picture 4",
"    </a>",
"    ). A strict biopsy protocol should be applied with four-quadrant biopsies taken immediately distal to the neosquamocolumnar junction (within 5 mm) and from every 1 to 2 cm of the neosquamous epithelium (",
"    <a class=\"graphic graphic_picture graphicRef74946 \" href=\"mobipreview.htm?19/11/19636\">",
"     picture 6",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    If residual BE is found, ablation can be repeated every 8 to 12 weeks until it has been eradicated both visually and histologically. Most patients will need one circumferential ablation session and one to two focal ablation sessions to eradicate all dysplasia and Barrett's mucosa. We suggest a maximum number of two circumferential and three focal ablation sessions, which should be sufficient in most patients.",
"   </p>",
"   <p>",
"    Since long-term follow-up data after RFA are lacking, it is recommended to schedule patients for follow-up endoscopy two and six months after the last treatment and then annually for surveillance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     EFFICACY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The efficacy of radiofrequency ablation (RFA) has been studied in porcine models, pre-esophagectomy human subjects, and human subjects undergoing surveillance for Barrett's esophagus (BE). Because the focal ablation device became available after the circumferential device, earlier studies focused on outcomes of circumferential RFA alone. More recent trials have included a stepwise approach of circumferential and focal RFA, as well as combining endoscopic mucosal resection with RFA.",
"   </p>",
"   <p>",
"    Evidence from a number of well-designed studies, including a randomized, sham-controlled trial, suggests that RFA is highly effective at removing all BE at both the endoscopic and histologic level with a favorable safety profile. Although long-term follow-up studies are still lacking, the five-year follow-up data suggest that eradication of the Barrett's mucosa is maintained in more than 90 percent of patients. In addition, studies of the properties of the neosquamous mucosa that regenerates after RFA show the absence of the pre-existing oncogenetic abnormalities, suggesting a permanent transition to a low-risk epithelium.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Eradication of Barrett's mucosa",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies have shown that RFA is effective for eradicating BE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/16-19\">",
"     16-19",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the Ablation of Intestinal Metaplasia Trial-II (AIM-II) trial, complete eradication of Barrett's mucosa at 12 months was achieved in 48 out of 70 subjects (70 percent) with non-dysplastic BE using only the HALO360 system for circumferential ablation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a follow-up study, the HALO90 device was used for additional ablation in patients from the AIM-II trial who had residual BE [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/18\">",
"       18",
"      </a>",
"      ]. At 30-month follow-up, complete remission of BE was found in 97 percent of patients by intention to treat analysis. None of the patients presented with esophageal stenosis and no buried Barrett's glands were found in any of the more than 4000 biopsies obtained during follow-up. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Buried Barrett's'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Fifty of the patients who had complete remission of BE at 30 months in the AIM-II trial were re-evaluated at five years [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/19\">",
"       19",
"      </a>",
"      ]. Complete remission of BE was noted in 46 patients (92 percent), whereas four patients (8 percent) had focal nondysplastic BE. The four patients with nondysplastic BE were all successfully treated with a single session of focal RFA.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Effect on dysplastic BE",
"    </span>",
"    &nbsp;&mdash;&nbsp;RFA has been shown to decrease the risk of malignant progression in patients with dysplastic BE. RFA eradicates all Barrett's mucosa in 67 to 100 percent of patients and eradicates dysplasia in 79 to 100 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/1,2,7,8,20-24\">",
"     1,2,7,8,20-24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The largest trials showed the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For ablation of BE in patients with LGD or HGD, the strongest evidence that RFA reduces the risk of malignant progression comes from a randomized sham-controlled trial (the AIM-dysplasia trial) that was conducted in 19 US centers and included 127 patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/7\">",
"       7",
"      </a>",
"      ]. Patients in the treatment arm could receive up to four treatments during the first year. At one-year follow-up, significantly higher proportions of RFA subjects had achieved complete remission for dysplasia and intestinal metaplasia compared with sham treated patients. In the HGD group, 81 percent of the patients who received RFA were free of intestinal metaplasia, compared with 19 percent of those who received sham therapy. In the LGD group, the rates were 91 and 23 percent, respectively. Overall, the rate of progression to higher grades of dysplasia or cancer was significantly lower in the RFA group than in the sham group (4 versus 16 percent).",
"      <br/>",
"      <br/>",
"      Patients who were initially assigned to the sham group were offered RFA after one year, and in total, 119 patients were treated with RFA [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/24\">",
"       24",
"      </a>",
"      ]. RFA was repeated at 15 months in patients who failed to achieve complete eradication of intestinal metaplasia at one year. In total, at the start of the follow-up period, there was complete eradication of dysplasia in 110 patients (92 percent) and eradication of intestinal metaplasia in 108 patients (91 percent). Two-year follow-up data were available for 106 patients. After two years of follow-up, 101 of 106 patients (95 percent) had complete eradication of dysplasia, including 50 of 54 patients (93 percent) with HGD and 51 of 52 patients (98 percent) with LGD. Eradication of intestinal metaplasia was seen in 99 of 106 patients (93 percent), including 48 of 54 patients (89 percent) with HGD and 51 of 52 patients (98 percent) with LGD. With no additional therapy, more than 85 percent of patients with HGD or LGD who were free of dysplasia at the start of follow-up were free of dysplasia after a mean of three years. Similarly, more than 75 percent of patients were free of intestinal metaplasia. Cancer developed in two patients (one with LGD and one with HGD), for an annual cancer risk of 0.55 percent.",
"     </li>",
"     <li>",
"      In a community-based study, 429 patients (primarily with non-dysplastic BE) underwent RFA using a stepwise approach with both circumferential and focal RFA [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/25\">",
"       25",
"      </a>",
"      ]. Follow-up biopsies were obtained in 338 patients. In the patients who had follow-up biopsies, BE was eradicated in 72 percent, and dysplasia was eradicated in 89 percent (median of follow-up of nine months). Safety data were available for all 429 patients. There were no serious adverse events or deaths, and strictures occurred in 2 percent of the patients.",
"      <br/>",
"      <br/>",
"      One year follow-up data were available for 137 patients (32 percent). In that cohort, the BE and dysplasia eradication rates were 77 and 100 percent, respectively (median follow-up of 20 months). However, given the large number of patients who lacked long-term follow-up, these results should be viewed with caution.",
"     </li>",
"     <li>",
"      In a prospective cohort study that included 63 patients with LGD and HGD, after a median follow-up of 24 months, 79 percent of patients were free of BE, and 89 percent were free of dysplasia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/20\">",
"       20",
"      </a>",
"      ]. For the subset of 39 patients with LGD, 87 percent were free of BE, and 95 percent were free of dysplasia; whereas for the subset of 24 patients with HGD, the rates were 67 and 79 percent, respectively.",
"     </li>",
"     <li>",
"      A retrospective series examined 112 patients with dysplastic BE who had complete eradication of dysplasia and intestinal metaplasia following RFA and were then followed with endoscopic surveillance for a median of 397 days [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/26\">",
"       26",
"      </a>",
"      ]. Disease recurrence was seen in eight patients (7 percent) and included progression to intramucosal cancer (one patient), progression to esophageal adenocarcinoma (two patients), HGD (one patient), LGD (one patients), and nondysplastic BE (three patients). The overall rate of BE recurrence was 5.2 percent per year, and the rate of BE recurrence with HGD or worse was 2.6 percent per year.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Combining endoscopic mucosal resection and RFA for high-grade dysplasia and intramucosal carcinoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with visible abnormalities in a segment of Barrett's esophagus (BE) that contains intramucosal carcinoma (IMC) or high-grade dysplasia (HGD) may be treated with radiofrequency ablation (RFA), but only after EMR of the IMC or visible lesion. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Visible lesions containing high-grade dysplasia or intramucosal carcinoma'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/38/10858?source=see_link\">",
"     \"Endoscopic resection for treatment of high-grade dysplasia and early cancer in Barrett's esophagus\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H21\">",
"     'Adverse events'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    There is concern that patients undergoing RFA following EMR may be at increased risk for complications. However, one study with 90 patients (44 who underwent RFA following EMR and 46 who only underwent RFA) did not find a difference in the rate of stricture formation between the groups [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/27\">",
"     27",
"    </a>",
"    ]. Patients who underwent RFA following EMR had a stricture rate of 14 percent, compared with 9 percent for those who underwent RFA alone (odds ratio 1.53; 95% confidence interval 0.26-9.74).",
"   </p>",
"   <p>",
"    An advantage of RFA over other ablation methods is that it does not appear to interfere with subsequent EMR for residual lesions. Studies suggest that it is possible to resect areas of Barrett's mucosa that persist after multiple RFA sessions using the ligate-and-cut technique, without the need for submucosal lifting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/2,8\">",
"     2,8",
"    </a>",
"    ]. Other endoscopic ablation techniques typically result in submucosal scarring, which complicates subsequent treatment with EMR.",
"   </p>",
"   <p>",
"    The ability to perform EMR for residual dysplastic tissue may explain the higher success rates in studies that incorporated EMR for residual BE (83 to 100 percent) compared with other RFA studies that did not [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/17,20,28\">",
"     17,20,28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Molecular markers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two clinical studies have evaluated molecular markers in esophageal tissue before and after RFA.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One study evaluated 21 patients with LGD and non-dysplastic BE [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/22\">",
"       22",
"      </a>",
"      ]. Microdissection specimens from multiple targets for each patient were assessed for a panel of 16 allelic imbalance mutational markers using quantitative fluorescent PCR with capillary electrophoresis at baseline and at up to 2.5 years after RFA. At baseline, all patients had multiple mutational abnormalities, but no abnormalities were detected at follow-up in the 15 patients with eradication of their BE. The study also found that cells with highly clonally expanded mutations were more resistant to initial RFA and required more ablation sessions for elimination.",
"     </li>",
"     <li>",
"      A number of genetic abnormalities associated with BE, dysplasia, and cancer were examined in 22 patients before and after RFA [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/23\">",
"       23",
"      </a>",
"      ]. These genetic abnormalities included immunohistochemistry (IHC) for Ki67 and p53, and fluorescent in situ hybridization (FISH) for numerical and chromosomal changes and loss of",
"      <span class=\"nowrap\">",
"       p16/p53.",
"      </span>",
"      All patients demonstrated multiple baseline abnormalities on both IHC and FISH. After RFA, dysplasia and Barrett's mucosa were eradicated in all patients, and none had residual abnormalities on IHC or FISH.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These studies suggest that the neosquamous epithelium that regenerates after RFA does not harbor residual malignant potential.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2432494\">",
"    <span class=\"h2\">",
"     Effect on quality of life",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients in the AIM-dysplasia trial were also evaluated to see if RFA had an effect on their quality of life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/29\">",
"     29",
"    </a>",
"    ]. At baseline, similar numbers of patients assigned to RFA and sham procedures reported worry about esophageal cancer (71 versus 85 percent, respectively) and worry about esophagectomy (61 versus 68 percent, respectively). Patients were also similar with regard to the",
"    <span class=\"nowrap\">",
"     presence/severity",
"    </span>",
"    of depression, impaired quality of life, worry, stress, and dissatisfaction with the condition of their esophagus.",
"   </p>",
"   <p>",
"    After undergoing an endoscopy 12 months following RFA or a sham procedure, patients were informed of their biopsy results (but not of their randomization group) and completed a second questionnaire. At follow-up, patients in the RFA group were less likely to be worried about esophageal cancer compared with those in the sham group (22 versus 66 percent) and were less likely to be worried about esophagectomy (17 versus 47 percent). They also showed significantly more improvement with regard to the",
"    <span class=\"nowrap\">",
"     presence/severity",
"    </span>",
"    of depression, impaired quality of life, worry, stress, and dissatisfaction with the condition of their esophagus.",
"   </p>",
"   <p>",
"    Interestingly, patients in the RFA group who did not achieve eradication of their BE still showed improvement in many of the quality of life domains, including worry about esophageal cancer and worry about esophagectomy, compared with those who underwent the sham procedure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     BURIED BARRETT'S",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is concern that residual Barrett's esophagus (BE) could be hidden beneath the neosquamous epithelium following ablation, but the clinical relevance of \"buried\" Barrett's is still uncertain.",
"   </p>",
"   <p>",
"    The possibility of occult malignant progression of the buried glands has been suggested by cases of adenocarcinoma arising underneath neosquamous epithelium after ablation therapy with radiofrequency ablation, photodynamic therapy, or argon plasma coagulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/30-32\">",
"     30-32",
"    </a>",
"    ]. However, because the Barrett's mucosa is protected from gastroesophageal refluxate by the neosquamous epithelium, the malignant potential of the buried glands may be lower than that seen with normal Barrett's mucosa [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/33,34\">",
"     33,34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Buried Barrett's prior to RFA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some of the clinical uncertainty is due to the observation that buried Barrett's glands may be seen in up to 28 percent of patients in the absence of treatment, suggesting that buried glands found following RFA may have been present prior to treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a sham-controlled study of 127 patients, 25 percent of the subjects had buried glands at baseline [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/7\">",
"     7",
"    </a>",
"    ]. At follow-up, only 5 percent of those treated with RFA were found to have buried glands, compared with 40 percent of subjects in the sham group (p &lt;0.001). Overall, in a systematic review that included 1004 patients who underwent RFA, buried metaplasia was found in only 1 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     False-negative results",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another concern is that buried Barrett's following RFA is under-recognized because the biopsies do not sample the neosquamous epithelium deeply enough [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/23,36\">",
"     23,36",
"    </a>",
"    ]. A study of 16 patients examined the sampling depth and presence of buried glands in biopsies and EMR specimens from neosquamous epithelium after RFA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/23\">",
"     23",
"    </a>",
"    ]. Four-quadrant routine biopsies were obtained every 2 cm from the neosquamous epithelium. Immediately after each routine biopsy, a second \"keyhole\" biopsy was taken from the same biopsy site to obtain a deeper sample. In addition, one set of four-quadrant routine biopsies was obtained from the untreated squamous epithelium of the proximal esophagus. Finally, a tissue sample from the neosquamous epithelium was obtained using endoscopic mucosal resection (EMR).",
"   </p>",
"   <p>",
"    The study showed:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      No difference in primary biopsy depth when comparing specimens obtained from the post-RFA neosquamous epithelium with specimens obtained from the untreated squamous epithelium (lamina propria present in 37 versus 36 percent of samples), suggesting that the post-RFA neosquamous epithelium is not more resistant to biopsy than untreated tissue.",
"     </li>",
"     <li>",
"      Keyhole biopsies and EMR sampled more deeply than routine biopsies (55 and 100 percent contained lamina propria, respectively).",
"     </li>",
"     <li>",
"      No buried Barrett's glands were detected in any of the primary, keyhole, or EMR specimens.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This study shows that biopsies obtained from squamous mucosa following RFA are similar to those obtained from normal squamous mucosa and that the low rate of buried glands reported after RFA compared with other ablation techniques is not a reflection of a sampling error specific to RFA. The absence of buried glands in all the specimens obtained in this study (including EMR specimens that sampled deep into the submucosa) is consistent with most clinical studies, in which buried glands are a rare finding. This suggests that RFA may be associated with complete eradication of all Barrett's epithelium.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     False-positive results",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tissue artifacts and residual BE may also lead to an incorrect diagnosis of buried Barrett's glands. Biopsies from neosquamous epithelium near the neosquamocolumnar junction may lead to sampling of the transition from neosquamous to columnar epithelium, leading to a histologic finding of glandular mucosa beneath the neosquamous epithelium, which may mistakenly be interpreted as buried Barrett's glands. In the case of a residual island of BE that was not treated with RFA, tangential sampling of the island combined with tangential sectioning of the biopsy may result in an erroneous finding of buried Barrett's [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A diagnosis of buried Barrett's glands should only be made if the endoscopist is positive that there were no residual BE islands after detailed inspection with narrow band imaging or Lugol's staining and if the biopsies were not obtained at the level of the neosquamocolumnar junction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/38\">",
"     38",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/40/29316?source=see_link\">",
"     \"Narrow band imaging in Barrett's esophagus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/0/15370?source=see_link&amp;anchor=H4#H4\">",
"     \"Chromoendoscopy\", section on 'Lugol's solution'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     ADVERSE EVENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adverse events reported with radiofrequency ablation (RFA) include esophageal strictures, upper gastrointestinal hemorrhage, and chest pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Stricture rates of 0 to 56 percent have been described with other endoscopic ablation techniques [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/39\">",
"     39",
"    </a>",
"    ]. Overall, studies of radiofrequency ablation (RFA) for Barrett's esophagus (BE) have shown lower rates of stricturing (0 to 6 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/7,8,18,25,40\">",
"     7,8,18,25,40",
"    </a>",
"    ]. The stricturing seen with RFA has generally been associated with either prior EMR or a narrow esophagus at baseline due to underlying reflux disease.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A study of 12 patients that compared measurements of esophageal inner diameter, motility, and compliance before RFA treatment and two months after the last ablation session showed no significant differences, suggesting that RFA does not impair the functional integrity of the esophagus [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/40\">",
"       40",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a sham-controlled study of 127 patients, 6 percent of the RFA cohort experienced a stricture, but all resolved with a mean of 2.6 dilations [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/7\">",
"       7",
"      </a>",
"      ]. There were no perforations or deaths.",
"     </li>",
"     <li>",
"      In a community-based registry of 429 patients, nine strictures occurred following 788 procedures (1 percent of cases, 2 percent of patients) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/25\">",
"       25",
"      </a>",
"      ]. All of the strictures resolved after a median of three dilations. There were no cases of bleeding (other than one patient who vomited blood-tinged mucus), perforation, or death.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Performing EMR prior to RFA may increase the risk of complications. In a study of 65 patients, there were no complications in the 18 patients who had not previously undergone EMR [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/41\">",
"     41",
"    </a>",
"    ]. In the 47 patients who had undergone EMR prior to circumferential RFA, mucosal lacerations were observed in patients who underwent RFA with a catheter that exceeded the smallest measured inner esophageal diameter and in patients whose EMR involved more than one-third of the esophageal circumference and was greater than 2.5 cm in length. Five cases of esophageal stenosis after RFA occurred, all in patients whose EMR involved more than 50 percent of the esophageal circumference and was longer than 2 cm in length.",
"   </p>",
"   <p>",
"    Based on these observations, it is advisable to limit the extent of EMR prior to RFA to less than 50 percent of the circumference of the esophagus and to less than 2 cm in length. In addition, the size of the ablation catheters should be chosen carefully. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Combining endoscopic mucosal resection and RFA for high-grade dysplasia and intramucosal carcinoma'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H8\">",
"     'Circumferential ablation'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     FOLLOW-UP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two to three months after the last treatment, the absence of residual Barrett's epithelium is confirmed by endoscopic inspection. The use of high-resolution endoscopes with Lugol's staining (2 percent) or preferably narrow band imaging is important to detect even small areas of residual IM. A strict biopsy protocol should be applied with 4 quadrant biopsies being taken immediately distal (&lt; 5 mm) to the neosquamocolumnar junction and from every 1-2 cm of the neosquamous epithelium. Since no long-term follow-up data after RFA are available, it is recommended to schedule patients for follow-up endoscopy two and six months after the last treatment and then annually.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     COST-EFFECTIVENESS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cost-effectiveness models have found radiofrequency ablation (RFA) to be cost-effective if certain assumptions are met:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One study used a Markov model in a hypothetical 50-year-old cohort with non-dysplastic Barrett's esophagus (BE) to evaluate three competing strategies: (1) no intervention (natural history), (2) surveillance alone, and (3) RFA. The assumptions were conservative and used an estimate of BE eradication rate with RFA of 50 percent, which was intentionally lower than rates reported in published studies. They concluded that patient age, cost of RFA, and BE eradication rates were critical determinants of the cost-effectiveness of RFA. Within a range of these parameters, RFA was a cost-effective strategy.",
"     </li>",
"     <li>",
"      A second model was designed to simulate the natural history of a cohort of patients with BE followed from age 50 until age 80 years or death [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/42\">",
"       42",
"      </a>",
"      ]. It compared the incremental cost-effectiveness between three competing strategies: (1) surveillance, (2) esophagectomy, and (3) RFA. Endoscopic ablation for patients with high-grade dysplasia increased life expectancy by three quality-adjusted years at an incremental cost of less than $6000 compared with no intervention. RFA was also the most cost-effective strategy in patients with low-grade dysplasia or no dysplasia if ablation permanently eradicated low-grade dysplasia in more than 28 percent of patients or non-dysplastic BE in more than 40 percent of patients. However, in order for RFA to be cost-effective, surveillance needed to stop after successful ablation.",
"     </li>",
"     <li>",
"      A third model used a hypothetical cohort of 50-year-old patients with BE either with or without dysplasia followed until the age of 80 years or death [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/53/41817/abstract/43\">",
"       43",
"      </a>",
"      ]. The model compared three strategies: endoscopic surveillance with surgery when cancer was detected; endoscopic surveillance with RFA when dysplasia was detected; or initial RFA followed by endoscopic surveillance.",
"      <br/>",
"      <br/>",
"      The study found that among patients with baseline high-grade dysplasia, initial RFA followed by endoscopic surveillance was more effective and less costly than the other approaches.",
"      <br/>",
"      <br/>",
"      For patients with baseline low-grade dysplasia, initial RFA had an incremental cost effectiveness ratio (ICER) of $18,231 per quality-adjusted life year (QALY) compared with endoscopic surveillance followed by RFA for high-grade dysplasia, assuming an annual rate of progression to cancer of 0.5 percent.",
"      <br/>",
"      <br/>",
"      For patients without baseline dysplasia, endoscopic surveillance followed by RFA for high-grade dysplasia was more effective and less costly than endoscopic surveillance followed by surgery once cancer developed. Compared with surveillance and RFA when high-grade dysplasia developed, initial RFA had unacceptably high ICERs per QALY of $205,500, $124,796, and $118,338 for annual rates of progression to cancer of 0.12, 0.33, and 0.5 percent, respectively.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?13/29/13778?source=see_link\">",
"       \"Patient information: Barrett's esophagus (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?2/39/2676?source=see_link\">",
"       \"Patient information: Barrett's esophagus (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiofrequency ablation (RFA) is an endoscopic treatment for Barrett's esophagus (BE), which studies suggest is highly effective at removing Barrett's mucosa and associated dysplasia.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      RFA is an option for the treatment of patients with dysplastic BE since RFA decreases their risk of malignant progression. Short to intermediate-term follow-up is promising, and five-year follow-up data suggest that the eradication of BE following RFA is maintained in more than 90 percent of patients. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Indications for RFA'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H12\">",
"       'Efficacy'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/61/35802?source=see_link&amp;anchor=H17#H17\">",
"       \"Management of Barrett's esophagus\", section on 'Radiofrequency ablation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For most patients with non-dysplastic BE, the net health benefit of RFA may be too low to justify its use. However, RFA can be considered for selected patients (eg, &lt;50 years old and a positive family history for esophageal adenocarcinoma). (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Non-dysplastic BE'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      RFA can be used in conjunction with endoscopic mucosal resection for raised high-grade dysplasia or intramucosal carcinoma. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Combining endoscopic mucosal resection and RFA for high-grade dysplasia and intramucosal carcinoma'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      RFA is performed with the HALO system, which is comprised of two distinct ablation systems: the HALO360 system for primary circumferential RFA and the HALO90 system for secondary focal RFA of BE. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Ablation procedures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Circumferential RFA involves inflation of a 3-cm long balloon ablation catheter within the esophagus at the site of the BE. The balloon contains an electrode array through which an electric current is applied, ablating the Barrett's mucosa. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Ablation procedures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Focal RFA to ablate small areas of BE also uses electrical energy to ablate the tissue and is delivered through a 20 mm x 13 mm electrode array attached to the end of the endoscope. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Ablation procedures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Adverse events reported with radiofrequency ablation (RFA) include esophageal strictures, upper gastrointestinal hemorrhage, and chest pain. These complications are generally mild, and severe complications are rare. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Adverse events'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      After RFA, acid suppressant therapy is important, not only to minimize patient discomfort, but also to allow the esophagus to heal optimally and regenerate with squamous epithelium. All patients should receive high-dose proton pump inhibitors as maintenance therapy. In addition, extra acid suppression after each treatment session is advisable. We prescribe all patients",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/39/15993?source=see_link\">",
"       esomeprazole",
"      </a>",
"      40 mg twice per day, supplemented with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?41/56/42888?source=see_link\">",
"       ranitidine",
"      </a>",
"      300 mg at bedtime, and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?28/29/29141?source=see_link\">",
"       sucralfate",
"      </a>",
"      suspension (200",
"      <span class=\"nowrap\">",
"       mg/mL)",
"      </span>",
"      5 mL four times a day for two weeks after each ablation session. The proton pump inhibitor is then continued for maintenance therapy. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Post-treatment care'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Two to three months after the last treatment, the absence of residual Barrett's epithelium is confirmed by endoscopic inspection. The use of high-resolution endoscopes with Lugol's staining (2 percent) or preferably narrow band imaging is important to detect even small areas of residual IM. Since no long-term follow-up data after RFA are available, it is recommended to schedule patients for follow-up endoscopy two and six months after the last treatment and then annually. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Follow-up'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/0/15370?source=see_link\">",
"       \"Chromoendoscopy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/1\">",
"      Gondrie JJ, Pouw RE, Sondermeijer CM, et al. Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the first prospective series of 11 patients. Endoscopy 2008; 40:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/2\">",
"      Gondrie JJ, Pouw RE, Sondermeijer CM, et al. Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy 2008; 40:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/3\">",
"      Peters FP, Brakenhoff KP, Curvers WL, et al. Histologic evaluation of resection specimens obtained at 293 endoscopic resections in Barrett's esophagus. Gastrointest Endosc 2008; 67:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/4\">",
"      van Sandick JW, van Lanschot JJ, ten Kate FJ, et al. Pathology of early invasive adenocarcinoma of the esophagus or esophagogastric junction: implications for therapeutic decision making. Cancer 2000; 88:2429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/5\">",
"      Westerterp M, Koppert LB, Buskens CJ, et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch 2005; 446:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/6\">",
"      May A, Gossner L, Pech O, et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol 2002; 14:1085.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/7\">",
"      Shaheen NJ, Sharma P, Overholt BF, et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med 2009; 360:2277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/8\">",
"      Pouw RE, Wirths K, Eisendrath P, et al. Efficacy of radiofrequency ablation combined with endoscopic resection for barrett's esophagus with early neoplasia. Clin Gastroenterol Hepatol 2010; 8:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/9\">",
"      Curvers WL, Rosmolen W, Elzer B, et al. Low-grade intraepithelial in Barrett's esophagus: over-diagnosed but underestimated [abstract]. Gastrointest Endosc 2008; 67:AB181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/10\">",
"      Dunkin BJ, Martinez J, Bejarano PA, et al. Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device. Surg Endosc 2006; 20:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/11\">",
"      Ganz RA, Utley DS, Stern RA, et al. Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus. Gastrointest Endosc 2004; 60:1002.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/12\">",
"      Smith CD, Bejarano PA, Melvin WS, et al. Endoscopic ablation of intestinal metaplasia containing high-grade dysplasia in esophagectomy patients using a balloon-based ablation system. Surg Endosc 2007; 21:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/13\">",
"      Gondrie JJ, Pouw RE, Sondermeijer CM, et al. Optimizing the technique for circumferential ablation of Barrett esophagus containing high-grade dysplasia using the HALO360 System [abstract]. Gastrointest Endosc 2007; 65:AB151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/14\">",
"      Krishnan K, Pandolfino JE, Kahrilas PJ, et al. Increased risk for persistent intestinal metaplasia in patients with Barrett's esophagus and uncontrolled reflux exposure before radiofrequency ablation. Gastroenterology 2012; 143:576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/15\">",
"      Akiyama J, Marcus SN, Triadafilopoulos G. Effective intra-esophageal acid control is associated with improved radiofrequency ablation outcomes in Barrett's esophagus. Dig Dis Sci 2012; 57:2625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/16\">",
"      Sharma VK, Kim HJ, Das A, et al. A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). Endoscopy 2008; 40:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/17\">",
"      Sharma VK, Wang KK, Overholt BF, et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc 2007; 65:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/18\">",
"      Fleischer DE, Overholt BF, Sharma VK, et al. Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up. Gastrointest Endosc 2008; 68:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/19\">",
"      Fleischer DE, Overholt BF, Sharma VK, et al. Endoscopic radiofrequency ablation for Barrett's esophagus: 5-year outcomes from a prospective multicenter trial. Endoscopy 2010; 42:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/20\">",
"      Sharma VK, Jae Kim H, Das A, et al. Circumferential and focal ablation of Barrett's esophagus containing dysplasia. Am J Gastroenterol 2009; 104:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/21\">",
"      van Vilsteren FG, Pouw RE, Seewald S, et al. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial. Gut 2011; 60:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/22\">",
"      Finkelstein SD, Lyday WD. The molecular pathology of radiofrequency mucosal ablation of Barrett's esophagus [abstract]. Gastroenterology 2008; 134:A436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/23\">",
"      Pouw RE, Gondrie JJ, Rygiel AM, et al. Properties of the neosquamous epithelium after radiofrequency ablation of Barrett's esophagus containing neoplasia. Am J Gastroenterol 2009; 104:1366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/24\">",
"      Shaheen NJ, Overholt BF, Sampliner RE, et al. Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. Gastroenterology 2011; 141:460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/25\">",
"      Lyday WD, Corbett FS, Kuperman DA, et al. Radiofrequency ablation of Barrett's esophagus: outcomes of 429 patients from a multicenter community practice registry. Endoscopy 2010; 42:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/26\">",
"      Orman ES, Kim HP, Bulsiewicz WJ, et al. Intestinal metaplasia recurs infrequently in patients successfully treated for Barrett's esophagus with radiofrequency ablation. Am J Gastroenterol 2013; 108:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/27\">",
"      Okoro NI, Tomizawa Y, Dunagan KT, et al. Safety of prior endoscopic mucosal resection in patients receiving radiofrequency ablation of Barrett's esophagus. Clin Gastroenterol Hepatol 2012; 10:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/28\">",
"      Ganz RA, Overholt BF, Sharma VK, et al. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry. Gastrointest Endosc 2008; 68:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/29\">",
"      Shaheen NJ, Peery AF, Hawes RH, et al. Quality of life following radiofrequency ablation of dysplastic Barrett's esophagus. Endoscopy 2010; 42:790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/30\">",
"      Mino-Kenudson M, Ban S, Ohana M, et al. Buried dysplasia and early adenocarcinoma arising in barrett esophagus after porfimer-photodynamic therapy. Am J Surg Pathol 2007; 31:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/31\">",
"      Van Laethem JL, Peny MO, Salmon I, et al. Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus. Gut 2000; 46:574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/32\">",
"      Titi M, Overhiser A, Ulusarac O, et al. Development of subsquamous high-grade dysplasia and adenocarcinoma after successful radiofrequency ablation of Barrett's esophagus. Gastroenterology 2012; 143:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/33\">",
"      Hornick JL, Blount PL, Sanchez CA, et al. Biologic properties of columnar epithelium underneath reepithelialized squamous mucosa in Barrett's esophagus. Am J Surg Pathol 2005; 29:372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/34\">",
"      Hornick JL, Mino-Kenudson M, Lauwers GY, et al. Buried Barrett's epithelium following photodynamic therapy shows reduced crypt proliferation and absence of DNA content abnormalities. Am J Gastroenterol 2008; 103:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/35\">",
"      Gray NA, Odze RD, Spechler SJ. Buried metaplasia after endoscopic ablation of Barrett's esophagus: a systematic review. Am J Gastroenterol 2011; 106:1899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/36\">",
"      Gupta N, Mathur SC, Dumot JA, et al. Adequacy of esophageal squamous mucosa specimens obtained during endoscopy: are standard biopsies sufficient for postablation surveillance in Barrett's esophagus? Gastrointest Endosc 2012; 75:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/37\">",
"      Pouw RE, Gondrie JJ, Sondermeijer CM, et al. Eradication of Barrett esophagus with early neoplasia by radiofrequency ablation, with or without endoscopic resection. J Gastrointest Surg 2008; 12:1627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/38\">",
"      Hernandez JC, Reicher S, Chung D, et al. Pilot series of radiofrequency ablation of Barrett's esophagus with or without neoplasia. Endoscopy 2008; 40:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/39\">",
"      Overholt BF, Lightdale CJ, Wang KK, et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc 2005; 62:488. Erratum in Gastrointest Endosc 2006; 63:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/40\">",
"      Beaumont H, Gondrie JJ, McMahon BP, et al. Stepwise radiofrequency ablation of Barrett's esophagus preserves esophageal inner diameter, compliance, and motility. Endoscopy 2009; 41:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/41\">",
"      Pouw RE, Gondrie JJ, van Vilsteren FGI, et al. Complications following circumferential Radiofrequency energy ablation of Barrett's esophagus containing early neoplasia [abstract]. Gastrointest Endosc 2008; 67:AB145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/42\">",
"      Inadomi JM, Somsouk M, Madanick RD, et al. A cost-utility analysis of ablative therapy for Barrett's esophagus. Gastroenterology 2009; 136:2101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/53/41817/abstract/43\">",
"      Hur C, Choi SE, Rubenstein JH, et al. The cost effectiveness of radiofrequency ablation for Barrett's esophagus. Gastroenterology 2012; 143:567.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2250 Version 20.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-183.1.191.153-09F22AFDA5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_53_41817=[""].join("\n");
var outline_f40_53_41817=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INDICATIONS FOR RFA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Visible lesions containing high-grade dysplasia or intramucosal carcinoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Flat high-grade dysplasia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Low-grade dysplasia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Non-dysplastic BE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      ABLATION PROCEDURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Circumferential ablation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Focal ablation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Post-treatment care",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Follow-up endoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      EFFICACY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Eradication of Barrett's mucosa",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Effect on dysplastic BE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Combining endoscopic mucosal resection and RFA for high-grade dysplasia and intramucosal carcinoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Molecular markers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2432494\">",
"      Effect on quality of life",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      BURIED BARRETT'S",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Buried Barrett's prior to RFA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      False-negative results",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      False-positive results",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      ADVERSE EVENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      FOLLOW-UP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      COST-EFFECTIVENESS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2250\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2250|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?20/51/21304\" title=\"figure 1\">",
"      Focal RFA Barretts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?17/13/17631\" title=\"figure 2\">",
"      HALO360 ablation catheter",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?37/54/38767\" title=\"figure 3\">",
"      HALO90 ablation catheter",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2250|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?23/40/24198\" title=\"picture 1\">",
"      Endosc resect and RFA HALO",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?9/60/10181\" title=\"picture 2\">",
"      Endosc RFA HALO360",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?19/50/20271\" title=\"picture 3\">",
"      HALO360 sizing balloon",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?30/33/31252\" title=\"picture 4\">",
"      Focal ablation HALO90",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?15/52/16196\" title=\"picture 5\">",
"      Endosc targeted RFA HALO90",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?19/11/19636\" title=\"picture 6\">",
"      Endosc long segment Barrett",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/27/13750?source=related_link\">",
"      Autofluorescence endoscopy for Barrett's esophagus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/0/15370?source=related_link\">",
"      Chromoendoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/38/10858?source=related_link\">",
"      Endoscopic resection for treatment of high-grade dysplasia and early cancer in Barrett's esophagus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/8/1161?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of Barrett's esophagus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/61/35802?source=related_link\">",
"      Management of Barrett's esophagus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/40/29316?source=related_link\">",
"      Narrow band imaging in Barrett's esophagus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/12/8391?source=related_link\">",
"      Pathogenesis of Barrett's esophagus and its malignant transformation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?2/39/2676?source=related_link\">",
"      Patient information: Barrett's esophagus (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?13/29/13778?source=related_link\">",
"      Patient information: Barrett's esophagus (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/27/26039?source=related_link\">",
"      Photodynamic therapy for ablation of Barrett's esophagus",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_53_41818="ECG Preexcitation WPW syndrome";
var content_f40_53_41818=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F81623&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F81623&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1184px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Electrocardiogram (ECG) showing preexcitation in WPW syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 439px; height: 313px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electrocardiogram showing normal sinus rhythm with ventricular preexcitation (Wolff-Parkinson-White syndrome). The PR interval is shortened at 0.10 sec and the delta waves are most prominent in leads I, aVL, and the lateral precordial leads (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Morton Arnsdorf, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 594px\">",
"   <div class=\"ttl\">",
"    Normal ECG",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 594px; height: 337px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal electrocardiogram showing normal sinus rhythm at a rate of 75 beats/min, a PR interval of 0.14 sec, a QRS interval of 0.10 sec, and a QRS axis of approximately 75&deg;.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_53_41818=[""].join("\n");
var outline_f40_53_41818=null;
var title_f40_53_41819="ATS ERS Dx Criteria IPF without Bx";
var content_f40_53_41819=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F54828&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F54828&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    ATS/ERS criteria for diagnosis of idiopathic pulmonary fibrosis in absence of surgical lung biopsy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Major criteria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Exclusion of other known causes of ILD such as certain drug toxicities, environmental exposures, and connective tissue diseases",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Abnormal pulmonary function studies that include evidence of restriction (reduced VC, often with an increased FEV1/FVC ratio) and impaired gas exchange [increased P(A-a)O",
"        <sub>",
"         2",
"        </sub>",
"        , decreased PaO",
"        <sub>",
"         2",
"        </sub>",
"        with rest or exercise or decreased DLco]",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bibasilar reticular abnormalities with minimal ground glass opacities on HRCT scans",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Transbronchial lung biopsy or BAL showing no features to support an alternative diagnosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Minor criteria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Age &gt;50 years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Insidious onset of otherwise unexplained dyspnea or exertion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Duration of illness &gt;3 months",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bibasilar, inspiratory crackles (dry or \"Velcro\"-type in quality)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     In the immunocompetent adult, the presence of all of the major diagnostic criteria as well as at least three of the four minor criteria increases the likelihood of a correct clinical diagnosis of IPF.",
"     <br>",
"      BAL: bronchoalveolar lavage; DLco: diffusing capacity of the lung for CO; HRCT: high-resolution computerized tomography; ILD: interstitial lung disease; P(A-a)O",
"      <sub>",
"       2",
"      </sub>",
"      : alveolar-arterial pressure differences for O",
"      <sub>",
"       2",
"      </sub>",
"      ; VC: vital capacity.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_53_41819=[""].join("\n");
var outline_f40_53_41819=null;
var title_f40_53_41820="Body packing overview";
var content_f40_53_41820=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F55939&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F55939&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Internal concealment of drugs of abuse (body packing)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        <span class=\"red\">",
"         To obtain emergent consultation with a medical toxicologist, call the United States Poison Control Network at 1-800-222-1222, or access the World Health Organization's list of international poison centers (",
"        </span>",
"        <a href=\"file://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html\" target=\"_blank\">",
"         www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html",
"        </a>",
"        <span class=\"red\">",
"         ).",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        History",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inquire about type of drug, method of wrapping, number of packets",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Physical exam",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Assess for heroin toxicity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Depressed mental status, decreased respirations, pinpoint pupils, absent bowel sounds",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Assess for cocaine toxicity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Agitation, hypertension, tachycardia, seizures, cardiac dysrhythmias",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Assess for evidence of packets on physical examination (abdominal and rectal exams)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Assess for evidence of gastrointestinal obstruction or perforation (distension, tenderness)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Diagnosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        A plain abdominal radiograph is the best screening study",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        If suspicion is high but plain radiograph is negative, CT (or barium enhanced abdominal radiography) should be performed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Urinalysis lacks sensitivity as a screening test, but may identify packet content(s)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Treatment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Asymptomatic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Whole bowel irrigation (polyethylene glycol electrolyte lavage solution), 2 L/h plus promotility agent (erythromycin 500 mg IV, or metoclopramide 10 mg IV)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Gastrointestinal obstruction or perforation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Surgical decontamination",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Evidence of heroin toxicity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Naloxone (high doses may be required: eg, 2 to 5 mg IV, may be given every 5 minutes until patient responsive)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Whole bowel irrigation, 2 L/h plus promotility agent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Evidence of cocaine toxicity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Benzodiazepines (eg, midazolam 1 to 2 mg IV, may be repeated); aggressive supportive care",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Surgical decontamination",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Endpoint of therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Contrast-enhanced abdominal CT (or barium-enhanced radiography) to document clearance of all packets from the GI tract",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_53_41820=[""].join("\n");
var outline_f40_53_41820=null;
var title_f40_53_41821="Number BPmeds HTNcontrol";
var content_f40_53_41821=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F58079&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F58079&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 483px\">",
"   <div class=\"ttl\">",
"    Average number of antihypertensive agents needed per patient to achieve target systolic BP goals",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 463px; height: 264px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Updated from: Bakris GL. Preserving renal function in adults with hypertension and diabetes: A consensus approach. Am J Kidney Dis 2000; 36:646.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_53_41821=[""].join("\n");
var outline_f40_53_41821=null;
var title_f40_53_41822="Trastuzumab plus cape and cis HER2 adv EG cancers";
var content_f40_53_41822=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F86570&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F86570&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Trastuzumab plus capecitabine and cisplatin for HER2-overexpressing advanced esophagogastric cancer",
"    <sup>",
"     [1]",
"    </sup>",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr class=\"divider_bottom\">",
"       <td colspan=\"4\">",
"        Cycle length: 21 days.",
"        <br/>",
"        Duration of therapy: 6 cycles.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dose and route",
"       </td>",
"       <td class=\"subtitle1\">",
"        Administration",
"       </td>",
"       <td class=\"subtitle1\">",
"        Given on days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Cisplatin",
"        </strong>",
"       </td>",
"       <td>",
"        80 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV",
"       </td>",
"       <td>",
"        <p>",
"         Dilute in 250 mL normal saline (NS)* and administer over 30 minutes or at a rate of 1 mg/min. Do not administer with aluminum needles or sets.",
"        </p>",
"        Alternative: Dilute in 2000 mL 5 percent dextrose in 1/2 or 1/3 NS containing 37.5 g of mannitol and infuse over a six to eight hour period",
"        <sup>",
"         [2]",
"        </sup>",
"        . Do not administer with aluminum needles or sets.",
"       </td>",
"       <td>",
"        Day 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Capecitabine",
"        </strong>",
"       </td>",
"       <td>",
"        1000 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        per dose by mouth",
"       </td>",
"       <td>",
"        Twice daily; take with water within 30 minutes after a meal.",
"       </td>",
"       <td>",
"        Days 1 through 14",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Trastuzumab",
"        </strong>",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        8 mg/kg IV loading dose",
"       </td>",
"       <td>",
"        Dilute in 250 mL NS and administer over 90 minutes. DO NOT mix with 5 percent dextrose in water (D5W) and DO NOT infuse as an IV push or bolus.",
"       </td>",
"       <td>",
"        Day 1, cycle 1 only",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Trastuzumab",
"        </strong>",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        6 mg/kg",
"        <sup>",
"        </sup>",
"        IV",
"       </td>",
"       <td>",
"        Dilute in 250 mL NS and administer over 30 minutes. DO NOT mix D5W and DO NOT infuse as an IV push or bolus.",
"       </td>",
"       <td>",
"        Day 1 of every subsequent cycle, starting with cycle 2",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Pretreatment considerations:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Hydration:",
"        </strong>",
"        IV fluid to establish a urine flow of at least 100 mL/hour for at least two hours prior to and two hours after cisplatin administration. Alternative: pretreatment hydration with 1 to 2 L of fluid infused for 8 to 12 hours prior to each dose of cisplatin",
"        <sup>",
"         [2]",
"        </sup>",
"        . Refer to UpToDate topic on \"Cisplatin-induced nephrotoxicity\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Emesis risk:",
"        </strong>",
"        HIGH (&gt;90 percent risk of emesis); prophylaxis for acute and delayed nausea and emesis through days 1 to 4 is warranted. Refer to UpToDate topic on \"Prevention and treatment of chemotherapy-induced nausea and vomiting\". According to the National Comprehensive Cancer Network (NCCN) Antiemesis Guidelines, cisplatin doses &gt;50 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        are considered of high emetic risk. While it is true the capecitabine given on days 2 through 14 is low risk, it may be confusing to practitioners to state that antiemetic risk is only high on day 1, since the period of nausea may last for several days.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Prophylaxis for infusion reactions:",
"        </strong>",
"        Routine prophylaxis not indicated for cisplatin. Most clinicians do not routinely premedicate prior to the first trastuzumab dose. However, patients may be instructed to self-administer acetaminophen or a nonsteroidal antiinflammatory drug (NSAID) if flu-like symptoms develop within 24 hours of drug administration. Refer to UpToDate topics on \"Infusion reactions to therapeutic monoclonal antibodies used for cancer therapy\" and \"Infusion reactions to systemic chemotherapy\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Vesicant/irritant properties:",
"        </strong>",
"        Cisplatin is an irritant but can cause significant tissue damage; avoid extravasation. Refer to UpToDate topic on \"Chemotherapy extravasation injury\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Infection prophylaxis:",
"        </strong>",
"        Primary prophylaxis with G-CSF is not indicated (estimated risk of febrile neutropenia is 5 percent",
"        <sup>",
"         [1]",
"        </sup>",
"        ). Refer to UpToDate topic on \"Use of granulocyte colony stimulating factors in patients with chemotherapy-induced neutropenia\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Dose adjustment for baseline liver or renal dysfunction:",
"        </strong>",
"        The optimal approach to cisplatin therapy in patients with preexisting renal impairment is unknown. A lower starting dose of capecitabine may be needed for patients with renal impairment. Refer to UpToDate topic on \"Chemotherapy-related nephrotoxicity and dose modification in patients with renal insufficiency\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Cardiopulmonary issues:",
"        </strong>",
"        Trastuzumab is associated with cardiotoxicity; assess baseline left ventricular ejection fraction (LVEF) prior to therapy. Patients with baseline LVEF less than 50 percent were excluded from this study",
"        <sup>",
"         [1]",
"        </sup>",
"        . Trastuzumab may cause serious pulmonary toxicity and should be used with caution in patients with preexisting pulmonary disease",
"        <sup>",
"         [3]",
"        </sup>",
"        . Refer to UpToDate topics on \"Cardiotoxicity of trastuzumab\" and \"Pulmonary toxicity associated with antineoplastic therapy: Molecularly targeted agents\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Monitoring parameters:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Obtain CBC with differential and platelet count prior to each new treatment cycle.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Assess electrolytes and liver and renal function prior to each new treatment cycle.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Monitor for hearing loss prior to each dose of cisplatin; audiometry as clinically indicated.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Monitor for infusion reactions, especially during the first two courses of trastuzumab.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Monitor for diarrhea and cutaneous toxicity (palmar-plantar erythrodysesthesias) due to capecitabine. Refer to UpToDate topic on \"Cutaneous complications of conventional chemotherapy agents\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Suggested dose modifications for toxicity:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Myelotoxicity:",
"        </strong>",
"        Hold new course of treatment until absolute neutrophil count is &ge;1500 cells/mm",
"        <sup>",
"         3",
"        </sup>",
"        and platelet count is &ge;100,000/mm",
"        <sup>",
"         3[2]",
"        </sup>",
"        .",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Nephrotoxicity:",
"        </strong>",
"        Hold cisplatin until serum creatinine &lt;1.5 mg/dL and/or blood urea nitrogen &lt;25 mg/dL. For grade &ge;2 nephrotoxicity during treatment (creatinine &gt;1.5 times normal value despite adequate hydration), creatinine clearance should be determined prior to next cycle, and cisplatin dose reduced (or switch to carboplatin) if &lt;60 mL/min. While this is clinically appropriate, there is not a specific reference in the US FDA-approved manufacturer's package insert outlining a change to carboplatin based on creatinine clearance of &lt;60 mL/min.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Cardiotoxicity:",
"        </strong>",
"        Reassess cardiac function as clinically indicated after starting trastuzumab. Guidelines for managing trastuzumab in patients with symptomatic or asymptomatic cardiac dysfunction during therapy are available. Refer to UpToDate topic on \"Cardiotoxicity of trastuzumab\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Pulmonary toxicity:",
"        </strong>",
"        Discontinue trastuzumab for serious pulmonary toxicity. Refer to UpToDate topic on \"Pulmonary toxicity associated with antineoplastic therapy: Molecularly targeted agents\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Neurologic toxicity:",
"        </strong>",
"        Neuropathy usually is seen with cumulative doses of cisplatin &gt;400 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        , although there is marked interindividual variation. Patients with mild neuropathy can continue to receive full cisplatin doses. However, if the neuropathy interferes with function, the risk of potentially disabling neurotoxicity must be weighed against the benefit of continued treatment. Refer to UpToDate topic on \"Neurologic complications of platinum-based chemotherapy\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Hand-foot syndrome and diarrhea/stomatitis:",
"        </strong>",
"        Hold capecitabine for grade 3 toxicity, and following recovery, reduce the dose by 25 percent for recurrent grade 2 or worse toxicity.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Other toxicity:",
"        </strong>",
"        Recommended dose modification guidelines for capecitabine are listed in the US FDA-approved manufacturer's product information. Interrupt therapy for grade 2 or 3 adverse event, and restart only after resolution to grade 1 or less. Following grade 3 toxicity, decrease subsequent doses of capecitabine. Doses of capecitabine omitted for toxicity are not replaced or restored; instead the patient should resume with the next planned treatment cycle",
"        <sup>",
"         [4]",
"        </sup>",
"        .",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <strong>",
"         If there is a change in body weight of at least 10 percent, doses should be recalculated.",
"        </strong>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <strong>",
"     This table is provided as an example of how to administer this regimen; there may be other acceptable methods. This regimen must be administered by a clinician trained in the use of chemotherapy. The clinician is expected to use his or her independent medical judgment in the context of individual circumstances to make adjustments, as necessary.",
"    </strong>",
"    <div class=\"footnotes\">",
"     IV: intravenous; G-CSF: granulocyte colony stimulating factor; CBC: complete blood count.",
"     <br/>",
"     * Diluent solutions should not be modified without consulting a detailed reference due to potential incompatibility(ies).",
"     <br/>",
"     &Delta; High levels of HER2 overexpression, as determined by either 3+ immunohistochemical staining (IHC) or positive fluorescence in situ hybridization (FISH), are used to select patients for therapy with trastuzumab. Refer to UpToDate topic \"HER2 and predicting response to therapy in breast cancer\".",
"     <br/>",
"     <span class=\"lozenge\">",
"      &loz;",
"     </span>",
"     In the original trial, cisplatin and capecitabine were stopped after six 21-day cycles, and trastuzumab alone continued on day 1 every 21 days until disease progression",
"     <sup>",
"      [1]",
"     </sup>",
"     .",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br/>",
"     <ol>",
"      <li>",
"       Bang J, et al. Lancet 2010; 376:687.",
"      </li>",
"      <li>",
"       Platinol (cisplatin) injection, powder, lyophilized, for solution. US FDA-approved manufacturer's package insert. US National Library of Medicine. (Available online at www.dailymed.nlm.nih.gov, accessed on June 7, 2012).",
"      </li>",
"      <li>",
"       Herceptin (trastuzumab) injection. US FDA-approved manufacturer's package insert. US National Library of Medicine. (Available online at dailymed.nlm.nih.gov, accessed on June 7, 2012).",
"      </li>",
"      <li>",
"       Xeloda (capecitabine). US FDA-approved manufacturer's package insert. US National Library of Medicine. (Available online at dailymed.nlm.nih.gov, accessed on June 7, 2012).",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_53_41822=[""].join("\n");
var outline_f40_53_41822=null;
var title_f40_53_41823="Congenital syphilis rash on soles";
var content_f40_53_41823=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F81352&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F81352&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Congenital syphilis: Rash on soles",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 233px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pigmented lesions on the soles of an infant with congenital syphilis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fleisher GR, Ludwig W, Baskin MN. Atlas of Pediatric Emergency Medicine. Lippincott Williams &amp; Wilkins, Philadelphia 2004. Copyright &copy; 2004 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_53_41823=[""].join("\n");
var outline_f40_53_41823=null;
